{"content":"<li class=\"n-box-item date-title\" data-end=\"1477972799\" data-start=\"1477886400\" data-txt=\"Sunday, December 22, 2019\">Monday, October 31, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3218879\" data-ts=\"1477959538\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRRX\" target=\"_blank\">DRRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218879-durects-durminus-928-shows-encouraging-activity-in-early-stage-nash-study-shares-up-16-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DURECT&#39;s DUR-928 shows encouraging activity in early-stage NASH study; shares up 16% after hours</a></h4><ul>\n<li>Micro cap DURECT (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DRRX\" title=\"Durect Corporation\">DRRX</a>) is up <font color=\"green\">16%</font> after hours on average volume in response to its announcement of promising data from the first cohort in a Phase 1b study assessing DUR-928 in patients with nonalcoholic steatohepatitis (NASH).</li>\n<li>The study is being conducted on successive cohorts evaluating single-dose levels of orally administered DUR-928. The first cohort involved 10 NASH subjects, including four with cirrhosis. The pharmacokinetic parameters were comparable between the NASH patients and matched control subjects. The study has proceeded to a higher dose cohort to evaluate a 4x larger dose than the low-dose group.</li>\n<li>Although the study was not designed to assess efficacy, patients receiving DUR-928 experienced a reduction in certain chemistry biomarkers for liver function and liver injury 12 hours post dosing. Also, C-reactive protein, a biomarker of liver inflammation, was also reduced a few hours after dosing while the effect was most pronounced in cirrhotic patients 12 hours post dosing.</li>\n<li>The company adds that additional studies are needed to confirm the therapeutic activity of DUR-928.</li>\n<li>\n<a href=\"http://www.durect.com/wt/durect/page_name/DUR-928\" target=\"_blank\">DUR-928</a> is a small molecule drug candidate that modulates the activity of various nuclear receptors involved in liver <a href=\"http://www.britannica.com/EBchecked/topic/270188/homeostasis\" target=\"_blank\">homeostasis </a>(stable function). It is under development for the potential treatment of nonalcoholic fatty liver disease (NAFLD) in addition to NASH. </li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218879\" data-linked=\"DURECT&#39;s DUR-928 shows encouraging activity in early-stage NASH study; shares up 16% after hours\" data-tweet=\"$DRRX - DURECT&#39;s DUR-928 shows encouraging activity in early-stage NASH study; shares up 16% after hours https://seekingalpha.com/news/3218879-durects-durminus-928-shows-encouraging-activity-in-early-stage-nash-study-shares-up-16-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3218879-durects-durminus-928-shows-encouraging-activity-in-early-stage-nash-study-shares-up-16-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218878\" data-ts=\"1477957399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTL\" target=\"_blank\">CTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218878-moodys-affirms-level-3-credit-ratings-in-wake-of-centurylink-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moody&#39;s affirms Level 3 credit ratings in wake of CenturyLink deal</a></h4><ul>   <li>The deal to be acquired by CenturyLink (<a href=\"https://seekingalpha.com/symbol/CTL\" title=\"CenturyLink, Inc.\">CTL</a> <font color=\"red\">-12.5%</font>) has gotten Level 3 Communications (<a href=\"https://seekingalpha.com/symbol/LVLT\" title=\"Level 3 Communications, Inc.\">LVLT</a> <font color=\"green\">+3.9%</font>) an affirmed credit rating, though a lower, <a href=\"https://www.moodys.com/research/Moodys-affirms-Level-3s-ratings-changes-outlook-to-stable--PR_357279?WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20161031_PR_357279\" target=\"_blank\">stable outlook</a> from Moody's.</li>    <li>The ratings company affirmed Level 3's Ba3 corporate family rating and its ratings of existing debt, and affirmed the Ba3 probability of default rating. It changed the outlook on Level 3 to stable from positive, though.</li>    <li>The acquisition isn't going to have much effect on existing debt instruments, Moody's says. The firm is putting CenturyLink's ratings on downgrade review, and it will focus on leverage and cash flows at the combined entity, along with growth potential.</li>    <li>Any downgrade to CenturyLink is expected to be contained to one notch (possibly to Ba3).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218878\" data-linked=\"Moody&#39;s affirms Level 3 credit ratings in wake of CenturyLink deal\" data-tweet=\"$CTL $CTL $LVLT - Moody&#39;s affirms Level 3 credit ratings in wake of CenturyLink deal https://seekingalpha.com/news/3218878-moodys-affirms-level-3-credit-ratings-in-wake-of-centurylink-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3218878-moodys-affirms-level-3-credit-ratings-in-wake-of-centurylink-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218876\" data-ts=\"1477956634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218876-time-warnerplus-1_7-fbr-upgrades-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Time Warner +1.7% as FBR upgrades to Outperform</a></h4><ul>   <li>Time Warner (<a href=\"https://seekingalpha.com/symbol/TWX\" title=\"Time Warner Inc.\">TWX</a> <font color=\"green\">+1.7%</font>) got a lift today, boosted by an upgrade at FBR to Outperform on prospects for a path to avoid FCC review of the company's deal to be bought out by AT&amp;T (NYSE:<a href=\"https://seekingalpha.com/symbol/T\" title=\"AT&amp;T Inc.\">T</a>).</li>    <li>Analyst Barton Crockett raised his target price to $104 from $97, implying near-17% upside from today's close of $88.99.</li>    <li>A small FCC license issue (a small station in Georgia, and uplink facilities for CNN) means the agency would have a hand in the review, but since Time Warner has already described those licenses as \"immaterial,\" Crockett notes it <a href=\"http://blogs.barrons.com/techtraderdaily/2016/10/31/fbr-ups-time-warner-to-buy-says-att-deal-could-avoid-fcc-review/\" target=\"_blank\">could just give them up</a>.</li>    <li>And avoiding FCC review \"vastly improves prospects for approval,\" he says. \"The FCC has a public interest standard and a loose timeline that can be politicized and make merger approval tough. While the DOJ will review this merger, it moves more quickly and acts based on antitrust law, and so is less politicized than the FCC.\"</li>    <li>It also helps politically that Netflix's Reed Hastings has been supportive of the deal, he notes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218876\" data-linked=\"Time Warner +1.7% as FBR upgrades to Outperform\" data-tweet=\"$T $T $TWX - Time Warner +1.7% as FBR upgrades to Outperform https://seekingalpha.com/news/3218876-time-warnerplus-1_7-fbr-upgrades-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3218876-time-warnerplus-1_7-fbr-upgrades-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218868\" data-ts=\"1477953670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LVLT\" target=\"_blank\">LVLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218868-level-3-sees-downgrades-analysts-refigure-ctl-merger-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Level 3 sees downgrades as analysts refigure CTL merger upside</a></h4><ul>   <li>While Level 3 Communications (<a href=\"https://seekingalpha.com/symbol/LVLT\" title=\"Level 3 Communications, Inc.\">LVLT</a> <font color=\"green\">+3.9%</font>) escaped CenturyLink's (<a href=\"https://seekingalpha.com/symbol/CTL\" title=\"CenturyLink, Inc.\">CTL</a> <font color=\"red\">-12.5%</font>) <a href=\"https://seekingalpha.com/news/3218718-centurylink-slides-12_8-percent-level-3-deal-dividend-may-safer\" target=\"_blank\">stock-price fate</a> on <a href=\"https://seekingalpha.com/news/3218527-centurylink-acquire-level-3-34b\" target=\"_blank\">confirmation of its buyout</a>, the company saw downgrades as analysts digested post-merger upside.</li>    <li>William Blair <a href=\"http://blogs.barrons.com/techtraderdaily/2016/10/31/centurylink-sinks-on-proposed-level-3-acquisition/\" target=\"_blank\">downgraded shares to Market Perform</a>, saying that while the merger makes for a better competitor to AT&amp;T and Verizon, growth could become an issue. \"Neither Level 3 nor CenturyLink has been aggressively investing in network build-outs to support customer dark fiber deployments, which has hindered wholesale expansion,\" writes Jim Breen. \"CenturyLink\u2019s consolidated revenue was declining, and Level 3's core enterprise revenue has been decelerating.\"</li>    <li>Cowen &amp; Co. cut to Hold as well, analyst Colby Synesael expects the deal's structure means the two stocks <a href=\"http://blogs.barrons.com/techtraderdaily/2016/10/31/cowen-co-drops-level-3-to-hold-on-centurylink-deal/\" target=\"_blank\">trade in line with each other</a>.</li>    <li>\"We'd point out that the real value of this deal from a CTL perspective is Level 3\u2019s FCF (plus the additional cost synergies),\" he writes, \"and to that point the reduction in Level 3 expected top-line performance has less impact on EBITDA/FCF as we note that even with the miss the company still managed to beat on EBITDA/FCF.\" He expects both companies' stocks to \"bleed up\" in coming quarters.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218868\" data-linked=\"Level 3 sees downgrades as analysts refigure CTL merger upside\" data-tweet=\"$LVLT $LVLT $CTL - Level 3 sees downgrades as analysts refigure CTL merger upside https://seekingalpha.com/news/3218868-level-3-sees-downgrades-analysts-refigure-ctl-merger-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3218868-level-3-sees-downgrades-analysts-refigure-ctl-merger-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218865\" data-ts=\"1477952566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APC\" target=\"_blank\">APC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218865-anadarko-petroleumminus-2_4-ah-following-bigger-expected-q3-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anadarko Petroleum -2.4% AH following bigger than expected Q3 loss</a></h4><ul>\n<li>Anadarko Petroleum (NYSE:<a href=\"https://seekingalpha.com/symbol/APC\" title=\"Anadarko Petroleum Corporation\">APC</a>) <font color=\"red\">-2.4%</font> AH after reporting a wider than expected <a href=\"https://seekingalpha.com/news/3218762-anadarko-petroleum-misses-0_32-misses-revenue\" target=\"_blank\">Q3 loss</a> and sharply lower than anticipated revenues; shares already had dropped 3.3% in regular trading, before the earnings announcement.</li>\n<li>APC says it is raising its FY 2016 divestiture-adjusted sales volume guidance  by 8M boe from the midpoint of initial expectations, and it increases its full-year monetization target for the second time this year, to $4B from $3.5B forecast in July.</li>\n<li>APC says it has accelerated activity  during Q3 with two additional rigs in both the Delaware Basin and the DJ Basin in  conjunction with its $2B deepwater Gulf of Mexico property  acquisition from Freeport McMoRan, which remains on track to close by year-end.</li>\n<li>APC also confirms earlier reports that it had <a href=\"http://www.upstreamonline.com/live/1447919/anadarko-details-hopkins-development-plan\" target=\"_blank\">taken over  operatorship</a> of BP's Hopkins discovery in the Gulf of Mexico.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218865\" data-linked=\"Anadarko Petroleum -2.4% AH following bigger than expected Q3 loss\" data-tweet=\"$APC - Anadarko Petroleum -2.4% AH following bigger than expected Q3 loss https://seekingalpha.com/news/3218865-anadarko-petroleumminus-2_4-ah-following-bigger-expected-q3-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3218865-anadarko-petroleumminus-2_4-ah-following-bigger-expected-q3-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218864\" data-ts=\"1477952429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218864-broadsoftminus-6_1-investors-absorb-dim-guidance-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BroadSoft -6.1% as investors absorb dim guidance, acquisition</a></h4><ul>   <li>BroadSoft (BSFT) <font color=\"red\">slipped 6.1%</font> today despite a <a href=\"https://seekingalpha.com/news/3218562-broadsoft-beats-0_15-beats-revenue\" target=\"_blank\">Q3 earnings beat</a> where it offered dim guidance for Q4 along with announcing an acquisition.</li>    <li>Overnight, the company said it acquired VoIP Logic and that the deal would dilute earnings by a penny while adding about $800,000 to revenue for 2016.</li>    <li>Revenue grew nearly 22% and GAAP net loss narrowed to just $0.6M vs. a year-ago loss of $3.3M. Non-GAAP net income was $16.4M vs. a year-ago $10.9M.</li>     <li>It's guiding to Q4 revenues of $94M-$102M, vs. consensus for $99.4M, and adjusted EPS of $0.65-$0.83, its midpoints below expectations for $0.78.</li>    <li>For the full year, it sees revenues of $333M-$341M  (vs. consensus for $337.7M) and non-GAAP EPS of $2.04-$2.22 (vs. $2.12 consensus).</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3218864\" data-linked=\"BroadSoft -6.1% as investors absorb dim guidance, acquisition\" data-tweet=\"$CSCO - BroadSoft -6.1% as investors absorb dim guidance, acquisition https://seekingalpha.com/news/3218864-broadsoftminus-6_1-investors-absorb-dim-guidance-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3218864-broadsoftminus-6_1-investors-absorb-dim-guidance-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218849\" data-ts=\"1477950170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBR\" target=\"_blank\">CBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218849-ciber-hires-adviser-strategic-alternatives-under-consideration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ciber hires adviser, strategic alternatives under consideration</a></h4><ul>\n<li>No timetable, direction or decision regarding any options disclosed.</li>\n<li>Ciber (NYSE:<a href=\"https://seekingalpha.com/symbol/CBR\" title=\"CIBER, Inc.\">CBR</a>) <font color=\"green\">+5%</font> after hours.</li>\n<li>Previously (September 15) \u2013 <a href=\"https://seekingalpha.com/news/3209028-ciber-plus-15-percent-bank-hire-rumored\" target=\"_blank\">Ciber +15%; bank hire rumored</a>\n</li>\n<li><a href=\"https://seekingalpha.com/filing/3271113\" target=\"_blank\">8-K</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218849\" data-linked=\"Ciber hires adviser, strategic alternatives under consideration\" data-tweet=\"$CBR - Ciber hires adviser, strategic alternatives under consideration https://seekingalpha.com/news/3218849-ciber-hires-adviser-strategic-alternatives-under-consideration?source=tweet\" data-url=\"https://seekingalpha.com/news/3218849-ciber-hires-adviser-strategic-alternatives-under-consideration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218847\" data-ts=\"1477949946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218847-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/RYAM' title='Rayonier Advanced Materials'>RYAM</a> <font color='green'>+11.8%</font>. <a href='https://seekingalpha.com/symbol/CGNX' title='Cognex Corporation'>CGNX</a> <font color='green'>+6.7%</font>. <a href='https://seekingalpha.com/symbol/AMKR' title='Amkor Technology, Inc.'>AMKR</a> <font color='green'>+6.3%</font>. <a href='https://seekingalpha.com/symbol/GEC' title='Great Elm Capital Group, Inc.'>GEC</a> <font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/LMNX' title='Luminex Corporation'>LMNX</a> <font color='green'>+3.3%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/INST' title='Instructure'>INST</a> <font color='red'>-25.5%</font>. <a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='red'>-8.7%</font>. <a href='https://seekingalpha.com/symbol/TEX' title='Terex Corporation'>TEX</a> <font color='red'>-5.7%</font>. <a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a> <font color='red'>-5.1%</font>. <a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='red'>-5.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218847\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$RYAM $CGNX $AMKR - After Hours Gainers / Losers https://seekingalpha.com/news/3218847-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3218847-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218832\" data-ts=\"1477948137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMKR\" target=\"_blank\">AMKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218832-amkor-technologyplus-5_7-48-q3-revenue-increase-posted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amkor Technology +5.7%, 48% Q3 revenue increase posted</a></h4><ul>\n<li>\n<strong><a href=\"https://seekingalpha.com/news/3218755-amkor-technology-beats-0_04-beats-revenue\" target=\"_blank\">Results</a></strong> \u2013 revenue $1.09B (+48.4% Y/Y, +18.4% Q/Q; <font color=\"green\">$30M above estimates</font>), EPS $0.25 (<font color=\"green\">$0.04 above estimates</font>), gross margin 19.7%, net income $60M, EBITDA $248M</li>\n<li>Q4 projections \u2013 net sales $990M-$1.07B (-1% to -9% Q/Q), gross margin 19%-23%, net income $46M-$82M</li>\n<li>FY 2016 projections \u2013 net sales $3.9B (vs. $2.9B Y/Y), gross margin 17.5% (vs. 16.6% Y/Y), net income $130M, capital expenditures $650M</li>\n<li>Amkor Technology (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMKR\" title=\"Amkor Technology, Inc.\">AMKR</a>) president and CEO Steve Kelley: \"We saw notable strength in smartphones across multiple tiers. Sales in Automotive, Greater China and advanced SiP were all up sequentially reflecting the continued success of our strategic initiatives in these key areas.\"</li>\n<li><a href=\"https://seekingalpha.com/symbol/AMKR/earnings\" target=\"_blank\">Prior quarters overview</a></li>\n<li><a href=\"http://edge.media-server.com/m/p/nzqkocdk/lan/en\" target=\"_blank\">Conference call</a></li>\n<li><a href=\"https://seekingalpha.com/filing/3270563\" target=\"_blank\">8-K</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218832\" data-linked=\"Amkor Technology +5.7%, 48% Q3 revenue increase posted\" data-tweet=\"$AMKR - Amkor Technology +5.7%, 48% Q3 revenue increase posted https://seekingalpha.com/news/3218832-amkor-technologyplus-5_7-48-q3-revenue-increase-posted?source=tweet\" data-url=\"https://seekingalpha.com/news/3218832-amkor-technologyplus-5_7-48-q3-revenue-increase-posted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218818\" data-ts=\"1477946703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218818-elephant-talk-becoming-pareteum-names-bozzo-new-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elephant Talk becoming Pareteum, names Bozzo new CEO</a></h4><ul>   <li>Elephant Talk Communications (<a href=\"https://seekingalpha.com/symbol/ETAK\" target=\"_blank\">ETAK</a> <font color=\"green\">+4%</font>) is changing names and changing leadership, with moves to rename itself Pareteum Corp. (based on the terms \"Pareto\" and \"Team\") and naming Vic Bozzo its new chief executive officer.</li>    <li>Both those changes are effective tomorrow. With the start of NYSE trading Thursday, the company will trade under a new ticker: <a href=\"https://seekingalpha.com/symbol/TEUM\" title=\"Pareteum Corporation\">TEUM</a>.</li>    <li>The company says that in combination with selling cybersecurity unit ValidSoft, its 12-month restructuring has ended successfully.</li>    <li>Bozzo previously led worldwide sales and marketing for Telarix, along with experience at Pac-West's Emerging Technologies division.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218818\" data-linked=\"Elephant Talk becoming Pareteum, names Bozzo new CEO\" data-tweet=\"$TEUM - Elephant Talk becoming Pareteum, names Bozzo new CEO https://seekingalpha.com/news/3218818-elephant-talk-becoming-pareteum-names-bozzo-new-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3218818-elephant-talk-becoming-pareteum-names-bozzo-new-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218799\" data-ts=\"1477946537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDTI\" target=\"_blank\">IDTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218799-integrated-device-technologyplus-2_6-eps-narrowly-above-expectations-revenue-below\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Integrated Device Technology +2.6%; EPS narrowly above expectations, revenue below</a></h4><ul>\n<li>\n<strong>Results</strong> \u2013 revenue $184.1M (+8.6%, <font color=\"red\">$1.01M below estimates</font>), EPS $0.34 (<font color=\"green\">$0.01 above estimates</font>), net income $47.4M (vs. $51.2M Q/Q, $53.9M Y/Y), gross profit $111.4M (vs. $117.9M Q/Q, $107.5M Y/Y), R&amp;D $35.3M (vs. $37.3M Q/Q, $31.5M Y/Y), SG&amp;A $28.2M (vs. $28.3 Q/Q, $23.5M Y/Y)</li>\n<li>Integrated Device Technology (NASDAQ:<a href=\"https://seekingalpha.com/symbol/IDTI\" title=\"Integrated Device Technology, Inc.\">IDTI</a>) president and CEO Gregory Waters: \"We are delivering new growth engines to the already strong IDT franchise, along with operating synergies that support our leadership financial model. We continue to make strong progress on our integration of ZMDI and have a clear line of sight to continued gains in operating results as we move through the fiscal year. Our new design-in funnel is extremely robust, with design-win traction and new technology innovation being delivered across all of our businesses.\"</li>\n<li><a href=\"https://seekingalpha.com/symbol/IDTI/earnings\" target=\"_blank\">Prior quarters overview</a></li>\n<li><a href=\"http://edge.media-server.com/m/p/7ce795nm\" target=\"_blank\">Conference call</a></li>\n<li><a href=\"http://files.shareholder.com/downloads/IDTI/3130274094x0x914587/14DC5FDA-3585-4E31-BB50-4FD41A8DAB92/IDTI_2Q17_Financial_Webcast_Slides.pdf\" target=\"_blank\">Presentation</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218799\" data-linked=\"Integrated Device Technology +2.6%; EPS narrowly above expectations, revenue below\" data-tweet=\"$IDTI - Integrated Device Technology +2.6%; EPS narrowly above expectations, revenue below https://seekingalpha.com/news/3218799-integrated-device-technologyplus-2_6-eps-narrowly-above-expectations-revenue-below?source=tweet\" data-url=\"https://seekingalpha.com/news/3218799-integrated-device-technologyplus-2_6-eps-narrowly-above-expectations-revenue-below\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218782\" data-ts=\"1477945061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218782-oil-tumbles-end-of-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil tumbles into the end of the month</a></h4><ul>\n<li>Black gold ended October lower than it started the month after a <font color=\"red\">4.1% decline </font>today to $46.69 per barrel.</li>\n<li>Making a good excuse for the selling<a href=\"http://www.marketwatch.com/story/oil-prices-slump-as-doubts-grow-over-opec-output-deal-2016-10-31\" target=\"_blank\"> is chatter about whether</a> OPEC can actually execute production cuts. In a weekend meeting of non-OPEC members, Azerbaijan, Brazil, Kazakhstan, Mexico, Oman and Russia all refused to commit to cuts or even freezes until OPEC reaches its own agreement.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a> <font color=\"red\">-4.35%</font>\n</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a>, <a href=\"https://seekingalpha.com/symbol/OIL\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a>, <a href=\"https://seekingalpha.com/symbol/UWTI\" title=\"VelocityShares 3x Long Crude Oil ETN\">UWTI</a>, <a href=\"https://seekingalpha.com/symbol/UCO\" title=\"ProShares Ultra Bloomberg Crude Oil ETF\">UCO</a>, <a href=\"https://seekingalpha.com/symbol/DWTI\" title=\"VelocityShares 3x Inverse Crude Oil ETN\">DWTI</a>, <a href=\"https://seekingalpha.com/symbol/SCO\" title=\"ProShares UltraShort Bloomberg Crude Oil ETF\">SCO</a>, <a href=\"https://seekingalpha.com/symbol/BNO\" title=\"The United States Brent Oil ETF, LP\">BNO</a>, <a href=\"https://seekingalpha.com/symbol/DBO\" title=\"PowerShares DB Oil ETF\">DBO</a>, <a href=\"https://seekingalpha.com/symbol/DTO\" title=\"DB Crude Oil Double Short ETN\">DTO</a>, <a href=\"https://seekingalpha.com/symbol/UGA\" title=\"The United States Gasoline ETF, LP\">UGA</a>, <a href=\"https://seekingalpha.com/symbol/USL\" title=\"The United States 12 Month Oil ETF, LP\">USL</a>, <a href=\"https://seekingalpha.com/symbol/DNO\" title=\"The United States Short Oil ETF, LP\">DNO</a>, <a href=\"https://seekingalpha.com/symbol/OLO\" title=\"DB Crude Oil Long ETN\">OLO</a>, <a href=\"https://seekingalpha.com/symbol/UHN\" title=\"The United States Diesel-Heating Oil ETF, LP\">UHN</a>, <a href=\"https://seekingalpha.com/symbol/SZO\" title=\"DB Crude Oil Short ETN\">SZO</a>, <a href=\"https://seekingalpha.com/symbol/OLEM\" title=\"iPath Pure Beta Crude Oil ETN\">OLEM</a>, <a href=\"https://seekingalpha.com/symbol/OILK\" title=\"ProShares K-1 Free Crude Oil Strategy ETF\">OILK</a>, <a href=\"https://seekingalpha.com/symbol/OILX\" title=\"Etracs S&amp;P GSCI Crude Oil Total Return Index ETN\">OILX</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218782\" data-linked=\"Oil tumbles into the end of the month\" data-tweet=\"$USO $OIL $UWTI - Oil tumbles into the end of the month https://seekingalpha.com/news/3218782-oil-tumbles-end-of-month?source=tweet\" data-url=\"https://seekingalpha.com/news/3218782-oil-tumbles-end-of-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218777\" data-ts=\"1477944961\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHFS\" target=\"_blank\">CHFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218777-sunshine-heart-inks-direct-placement-of-convertible-stock-shares-down-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunshine Heart inks direct placement of convertible stock; shares down 15%</a></h4><ul>\n<li>Thinly traded nano cap Sunshine Heart (SSH) went south <font color=\"red\">15%</font> today on more than triple normal volume, albeit on turnover of only 189K shares, in response to the company's announcement that it has entered int an agreement with an institutional investor for two series of convertible preferred stock for gross proceeds of $3.8M.</li>\n<li>The deal involves the issuance of 2,900 registered shares of Series C Convertible Preferred Stock that will be convertible into a total of 17,058,824 share of common stock at $0.17. Also included is the issuance of 900 unregistered Series D Convertible Preferred Stock that will be convertible into a total of 5,294,118 shares of common at $0.17. The investor will also receive five-year warrants to purchase up to 22,352,941 shares of common at $0.18.</li>\n<li>The preferred stock is not convertible and the warrants not exercisable until approved by Sunshine shareholders.</li>\n<li>Today's close was $0.21.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218777\" data-linked=\"Sunshine Heart inks direct placement of convertible stock; shares down 15%\" data-tweet=\"$CHFS - Sunshine Heart inks direct placement of convertible stock; shares down 15% https://seekingalpha.com/news/3218777-sunshine-heart-inks-direct-placement-of-convertible-stock-shares-down-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3218777-sunshine-heart-inks-direct-placement-of-convertible-stock-shares-down-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218750\" data-ts=\"1477944126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OFIX\" target=\"_blank\">OFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218750-orthofix-beats-0_05-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orthofix beats by $0.05, misses on revenue</a></h4><ul>\n<li>Orthofix (NASDAQ:<a href=\"https://seekingalpha.com/symbol/OFIX\" title=\"Orthofix International N.V.\">OFIX</a>): Q3 EPS of $0.36 <font color=\"green\">beats by $0.05</font>.</li>\n<li>Revenue of $98.5M (-2.6% Y/Y) <font color=\"red\">misses by $4.9M</font>.</li>\n<li>Shares <font color=\"green\">+4.6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218750\" data-linked=\"Orthofix beats by $0.05, misses on revenue\" data-tweet=\"$OFIX - Orthofix beats by $0.05, misses on revenue https://seekingalpha.com/news/3218750-orthofix-beats-0_05-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3218750-orthofix-beats-0_05-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218747\" data-ts=\"1477943874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRCD\" target=\"_blank\">BRCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218747-brocadeplus-22_3-give-broadcom-vertical-integration-stifel-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brocade +22.3%; could give Broadcom vertical integration, Stifel says</a></h4><ul>   <li>Brocade Communications (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BRCD\" title=\"Brocade Communications Systems, Inc.\">BRCD</a>) is <font color=\"green\">up 22.3%</font> and hanging right at 52-week high range after news that it's <a href=\"https://www.bloomberg.com/news/articles/2016-10-31/brocade-communications-said-in-advanced-talks-to-sell-itself?cmpid=yhoo.headline&amp;yptr=yahoo\" target=\"_blank\">in talks to sell itself</a> and getting close to the end of that process.</li>    <li>A deal could be announced this week, Bloomberg reports, and one of the interested parties is reportedly Broadcom (<a href=\"https://seekingalpha.com/symbol/AVGO\" title=\"Broadcom Limited\">AVGO</a> <font color=\"green\">+0.7%</font>), which could be interested in supplementing its switch-chip business with Brocade's networking gear. Broadcom CEO Hock Tan has said he's interested in acquisitions.</li>    <li>Such a deal might allow for better competition against much bigger rival Cisco Systems (<a href=\"https://seekingalpha.com/symbol/CSCO\" title=\"Cisco Systems, Inc.\">CSCO</a> <font color=\"green\">+0.4%</font>). \"A purchase by Broadcom (Avago) would be a strategic <a href=\"http://www.streetinsider.com/Analyst+Comments/Brocade+%28BRCD%29+Deal+Would+Equal+Vertical+Integration+for+Broadcom+%28AVGO%29+-+Stifel/12186064.html\" target=\"_blank\">move by Broadcom to vertically integrate</a> in an IP switching and routing market that has increasingly moved to merchant silicon,\" notes Stifel analyst Aaron Rakers.</li>    <li>He's maintained a Hold rating and $10 price target (the boost today has put Brocade at $10.63). He doesn't know any inside information about activity around Brocade this week but notes that for years, talk has persisted that Brocade might sell itself to suitors like H-P (NYSE:<a href=\"https://seekingalpha.com/symbol/HPQ\" title=\"HP Inc.\">HPQ</a>), Oracle (NYSE:<a href=\"https://seekingalpha.com/symbol/ORCL\" title=\"Oracle Corporation\">ORCL</a>) or IBM (NYSE:<a href=\"https://seekingalpha.com/symbol/IBM\" title=\"International Business Machines Corporation\">IBM</a>).</li>    <li>With current net debt (about $440M) and at $11/share, Brocade would come at about a $4.9B enterprise value, 7.3 times EBITDA, he says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218747\" data-linked=\"Brocade +22.3%; could give Broadcom vertical integration, Stifel says\" data-tweet=\"$BRCD $BRCD $AVGO - Brocade +22.3%; could give Broadcom vertical integration, Stifel says https://seekingalpha.com/news/3218747-brocadeplus-22_3-give-broadcom-vertical-integration-stifel-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3218747-brocadeplus-22_3-give-broadcom-vertical-integration-stifel-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218745\" data-ts=\"1477943831\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSA\" target=\"_blank\">MSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218745-msa-safetyplus-5_5-after-baird-upgrades-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MSA Safety +5.5% after Baird upgrades to Outperform</a></h4><ul>     <li>MSA Safety (<a href=\"https://seekingalpha.com/symbol/MSA\" title=\"MSA Safety Inc\">MSA</a> <font color=\"green\">+5.5%</font>) surges to a 52-week high after Baird <a href=\"http://www.streetinsider.com/Upgrades/Baird+Upgrades+MSA+Safety+%28MSA%29+to+Outperform/12183863.html\" target=\"_blank\">upgrades shares to Outperform</a> from Neutral and hikes the stock price target to $63 from $57.</li>\n<li>Baird cites another <a href=\"https://seekingalpha.com/news/3217994-msa-safety-beats-0_06-misses-revenue\" target=\"_blank\">strong quarter</a> of execution at MSA with rising margins, continued  competitive SCBA wins and improvement in sales breadth and apparent  stabilization in several key industrial products.</li>\n<li>The firm says MSA's sales backdrop remains choppy but another round of restructuring aids profit visibility and demonstrates the company's determination to drive better returns while still investing to drive competitive growth.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218745\" data-linked=\"MSA Safety +5.5% after Baird upgrades to Outperform\" data-tweet=\"$MSA - MSA Safety +5.5% after Baird upgrades to Outperform https://seekingalpha.com/news/3218745-msa-safetyplus-5_5-after-baird-upgrades-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3218745-msa-safetyplus-5_5-after-baird-upgrades-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218742\" data-ts=\"1477943374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218742-new-low-for-chipotle-on-e-coli-anniversary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A new low for Chipotle on its E. coli anniversary</a></h4><ul> <li>Chipotle (<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a> <font color='red'>-2.4%</font>) drifts lower again to a session low of $360.15. The restaurant stock is also at a new multi-year low.</li> <li>It's been exactly one year since the restaurant chain fell victim to a devastating E. coli outbreak.</li> <li>Looking ahead, SA contributor Kevin Wenck <a href=\"https://seekingalpha.com/article/4016886-chipotle-loses-2000-future-units\" target=\"_blank\">notes</a> the company's decision to shutter ShopHouse takes some of the punch out if its growth potential.</li> <li>\"The failure of the ShopHouse concept as an expansion vehicle shows the limitations and lack of capabilities of CMG management,\" he adds.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218742\" data-linked=\"A new low for Chipotle on its E. coli anniversary\" data-tweet=\"$CMG - A new low for Chipotle on its E. coli anniversary https://seekingalpha.com/news/3218742-new-low-for-chipotle-on-e-coli-anniversary?source=tweet\" data-url=\"https://seekingalpha.com/news/3218742-new-low-for-chipotle-on-e-coli-anniversary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218743\" data-ts=\"1477943342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVEP-OLD\" target=\"_blank\">EVEP-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218743-ev-energyminus-15-stifel-cuts-shares-to-hold-from-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EV Energy -15% as Stifel cuts shares to Hold from Buy</a></h4><ul>     <li>EV Energy (<a href=\"https://seekingalpha.com/symbol/EVEP-OLD\" title=\"EV Energy Partners, L.P.\">EVEP-OLD</a> <font color=\"red\">-15.2%</font>) plunges after Stifel <a href=\"http://www.streetinsider.com/Analyst+PT+Change/UPDATE%3A+Stifel+Downgrades+EV+Energy+Partners+%28EVEP%29+to+Hold/12183674.html\" target=\"_blank\">downgrades shares to Hold</a> from Buy with a $2 price target, chopped in half from $4, even as the firm looks for the capital markets to improve for traditional upstream MLPs.</li>     <li>Stifel says it continues to view EVEP as the best  positioned to weather the crude oil downturn given the ~40% availability under its credit facility entering the fall re-determination.</li>     <li>However, the firm sees limited growth in the current commodity environment, as the company's focus remains on balance sheet management and, in turn, limited potential value creation for equityholders.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218743\" data-linked=\"EV Energy -15% as Stifel cuts shares to Hold from Buy\" data-tweet=\"$EVEP-OLD - EV Energy -15% as Stifel cuts shares to Hold from Buy https://seekingalpha.com/news/3218743-ev-energyminus-15-stifel-cuts-shares-to-hold-from-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3218743-ev-energyminus-15-stifel-cuts-shares-to-hold-from-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218741\" data-ts=\"1477943077\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218741-valeant-ex-ceo-and-ex-cfo-focus-of-criminal-probe-shares-sink-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant ex-CEO and ex-CFO focus of criminal probe; shares sink 7%</a></h4><ul>\n<li>Valeant Pharmaceuticals (VRX <font color=\"red\">-6.8%</font>) slumps on increased volume in response in response to the <a href=\"http://www.bloomberg.com/news/articles/2016-10-31/valeant-ex-ceo-ex-cfo-are-focus-of-u-s-criminal-probe?cmpid=socialflow-twitter-business&amp;utm_content=business&amp;utm_campaign=socialflow-organic&amp;utm_source=twitter&amp;utm_medium=social\" target=\"_blank\">news </a>that ex-CEO Michael Pearson and ex-CFO Howard Schiller are the focus of a fraud investigation by the U.S. Department of Justice.</li>\n<li>\n<strong>Update</strong>: Bloomberg <a href=\"http://www.bloomberg.com/news/articles/2016-10-31/valeant-ex-ceo-ex-cfo-said-to-be-a-focus-of-u-s-criminal-probe\" target=\"_blank\">reports </a>that the DOJ could bring charges within weeks against the two men. The nature of the fraud charges are related to the company's hidden ties to now-defunct Philidor, a specialty pharmacy that used dubious tactics to increase insurance reimbursements for Valeant products. In late 2014, the company paid $100M for an option to buy Philidor. The potential deal unraveled when the news broke about the relationship and Valeant admitted that it incorrectly recorded shipments to Philidor as revenue.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218741\" data-linked=\"Valeant ex-CEO and ex-CFO focus of criminal probe; shares sink 7%\" data-tweet=\"$BHC - Valeant ex-CEO and ex-CFO focus of criminal probe; shares sink 7% https://seekingalpha.com/news/3218741-valeant-ex-ceo-and-ex-cfo-focus-of-criminal-probe-shares-sink-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3218741-valeant-ex-ceo-and-ex-cfo-focus-of-criminal-probe-shares-sink-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>322&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218738\" data-ts=\"1477942970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218738-chipotle-heads-lower-on-report-of-criminal-probe-of-valeant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle heads lower on report of criminal probe of Valeant</a></h4><ul>\n<li>Valeant has<font color=\"red\"> tumbled more than 5%</font> as Bloomberg reports<a href=\"https://twitter.com/bored2tears/status/793174567753691136\" target=\"_blank\"> the government as</a> probing the company, and maybe ex-management, for potential accounting fraud charges.</li>\n<li>The news is leaking into another big Bill Ackman investment, Chipotle (<a href=\"https://seekingalpha.com/symbol/CMG\" title=\"Chipotle Mexican Grill, Inc.\">CMG</a> <font color=\"red\">-2.6%</font>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218738\" data-linked=\"Chipotle heads lower on report of criminal probe of Valeant\" data-tweet=\"$CMG - Chipotle heads lower on report of criminal probe of Valeant https://seekingalpha.com/news/3218738-chipotle-heads-lower-on-report-of-criminal-probe-of-valeant?source=tweet\" data-url=\"https://seekingalpha.com/news/3218738-chipotle-heads-lower-on-report-of-criminal-probe-of-valeant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218740\" data-ts=\"1477942704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SO\" target=\"_blank\">SO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218740-southern-coplus-2-after-strong-q3-results-optimistic-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southern Co. +2% after strong Q3 results, optimistic guidance</a></h4><ul>     <li>Southern Co. (<a href=\"https://seekingalpha.com/symbol/SO\" title=\"Southern Company\">SO</a> <font color=\"green\">+2%</font>) maintains strong gains after posting a solid <a href=\"https://seekingalpha.com/news/3218550-southern-beats-0_11-beats-revenue\" target=\"_blank\">Q3 earnings</a> beat on a 16% Y/Y gain in operating revenue to $6.26B, <a href=\"http://www.wsj.com/articles/southern-co-revenue-and-profit-rise-1477917191\" target=\"_blank\">citing</a> warmer than normal weather, retail revenue effects at its traditional electric operating companies, and a stronger than expected performance of its Southern Power subsidiary.</li>     <li>EPS growth could have been even more robust if not for the adverse impact of an increase in shares outstanding.</li>     <li>SO says total Q3 electricity sales volume rose 5.7% Y/Y, with retail electricity sales rising 3.2% and wholesale volume gaining 18%.</li>     <li>Along with the positive Q3 report, SO offered reassuring guidance at its analyst day, seeing adjusted FY 2016 EPS at the very top of the $2.76-$2.88  guidance range and adjusted FY 2017 EPS of $2.in90-$3.02, which  brackets analyst consensus.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218740\" data-linked=\"Southern Co. +2% after strong Q3 results, optimistic guidance\" data-tweet=\"$SO - Southern Co. +2% after strong Q3 results, optimistic guidance https://seekingalpha.com/news/3218740-southern-coplus-2-after-strong-q3-results-optimistic-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3218740-southern-coplus-2-after-strong-q3-results-optimistic-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218734\" data-ts=\"1477941960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218734-madea-holds-off-hanks-for-another-weekend-atop-box-office\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Madea&#39; holds off Hanks for another weekend atop box office</a></h4><ul>   <li>Tyler Perry continued to rack up scary sums as <i>Boo! A Madea Halloween</i> (<a href=\"https://seekingalpha.com/symbol/LGF\" target=\"_blank\">LGF</a> <font color='green'>+1.6%</font>) held the weekend's box-office crown against a disappointing home debut in Tom Hanks' Dan Brown film series.</li>    <li><i>Inferno</i> (<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a> <font color='red'>-0.8%</font>), the follow-up to 2006's <i>The Da Vinci Code</i> and 2009's <i>Angels &amp; Demons,</i> drew just $15M to finish No. 2 against <i>Madea's</i> $16.7M. That's well off the $77M <i>The Da Vinci Code</i> opened with domestically, but <i>Inferno</i> has already drawn $132.7M from international openings.</li>    <li>Similarly, <i>Doctor Strange</i> -- the latest entry in the Marvel (<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> <font color='red'>-1.2%</font>) Cinematic Universe -- won't open in the U.S. until Friday, but drew $86M in overseas openings.</li>    <li>Rounding out the top five films: <i>Jack Reacher: Never Go Back</i> (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> flat, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> -0.3%) was No. 3 with $9.6M; <i>The Accountant</i> (TWX +1.2%) No. 4 with $8.48M; and <i>Ouija: Origin of Evil</i> (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) fifth with $7.1M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218734\" data-linked=\"&#39;Madea&#39; holds off Hanks for another weekend atop box office\" data-tweet=\"$VIA $VIA $VIAB - &#39;Madea&#39; holds off Hanks for another weekend atop box office https://seekingalpha.com/news/3218734-madea-holds-off-hanks-for-another-weekend-atop-box-office?source=tweet\" data-url=\"https://seekingalpha.com/news/3218734-madea-holds-off-hanks-for-another-weekend-atop-box-office\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218728\" data-ts=\"1477940327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APO\" target=\"_blank\">APO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218728-apollo-global-price-target-boosted-ubs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apollo Global price target boosted at UBS</a></h4><ul>\n<li>Apollo Global (NYSE:<a href=\"https://seekingalpha.com/symbol/APO\" title=\"Apollo Global Management, LLC\">APO</a>) on Friday<a href=\"https://seekingalpha.com/news/3218154-strong-p-e-fund-results-boost-apollos-quarter\" target=\"_blank\"> reported a far stronger</a> than expected Q3, but was unable to hold gains amid a jittery market that afternoon, and as investors maybe booked some profits after more than a 50% run higher for the stock since February.</li>\n<li>Reiterating a Buy rating and boosting the price target to $24 from $20 (30%+ upside), UBS's Brennan Hawken is impressed with how much money Apollo put to work in Fund VIII Q3, thus allowing fundraising to get going for Fund IX.</li>\n<li>Importantly, Apollo isn't just throwing money at deals - the average deal in Fund VIII was done at about 6x EBITDA (vs. industry average of 11x), and the fund was in carry for a 2nd straight quarter despite still being in investment phase.</li>\n<li>\"We believe the firm's willingness to do more complex deals has aided in finding attractive areas to put capital to work and should bode well for returns and realizations as these funds season.\"</li>\n<li>Shares <font color=\"green\">+1.15%</font> today.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218728\" data-linked=\"Apollo Global price target boosted at UBS\" data-tweet=\"$APO - Apollo Global price target boosted at UBS https://seekingalpha.com/news/3218728-apollo-global-price-target-boosted-ubs?source=tweet\" data-url=\"https://seekingalpha.com/news/3218728-apollo-global-price-target-boosted-ubs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218727\" data-ts=\"1477940228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRC\" target=\"_blank\">RRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218727-range-resources-raised-to-conviction-buy-from-neutral-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Range Resources raised to Conviction Buy from Neutral at Goldman</a></h4><ul>     <li>Range Resources (<a href=\"https://seekingalpha.com/symbol/RRC\" title=\"Range Resources Corporation\">RRC</a> <font color=\"red\">-1.8%</font>) is lower despite earning an <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Range+Resources+%28RRC%29+to+Conviction+Buy/12184250.html\" target=\"_blank\">upgrade to Conviction Buy</a> from Neutral with a $47 price target at Goldman Sachs, which highlights the company's exposure to gas and natural gas liquids, underappreciated production growth and valuation.</li>\n<li>Relative to other gassy E&amp;Ps, RRC is more favorably exposed to Henry  Hub and NGL prices, where the firm sees near-term upside, and less exposed to  local Appalachia prices.</li>\n<li>Goldman also says RRC\u2019s recent acquisition of Louisiana assets adds ability to flex  production between Appalachia and Louisiana to mitigate risk of pipeline  delays and/or regional price differences.</li>\n<li>The firm adds that RRC\u2019s EV/EBITDA multiple reflects a below-historical premium, particularly on 2018 estimates despite continued superior resource life.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218727\" data-linked=\"Range Resources raised to Conviction Buy from Neutral at Goldman\" data-tweet=\"$RRC - Range Resources raised to Conviction Buy from Neutral at Goldman https://seekingalpha.com/news/3218727-range-resources-raised-to-conviction-buy-from-neutral-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/3218727-range-resources-raised-to-conviction-buy-from-neutral-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218726\" data-ts=\"1477940046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVH\" target=\"_blank\">PVH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218726-speculation-circulates-on-michael-kors-pvh-merger-of-equals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Speculation circulates on a Michael Kors-PVH merger of equals</a></h4><ul> <li>The Betaville website is out with a new M&amp;A tip that has traders scrambling.</li> <li>Ben Harrington says PVH Corp (NYSE:<a href=\"https://seekingalpha.com/symbol/PVH\" title=\"PVH Corp.\">PVH</a>) is considering making a <a href=\"https://twitter.com/LaMonicaBuzz/status/793158660381900802\" target=\"_blank\">run</a> at Michael Kors (KORS). It wouldn't be the easiest of deals considering that KORS actually has a slightly higher market cap (PVH has the higher enterprise value).</li> <li>Shares of Michael Kors are 8% higher over the last three weeks amid some lingering  M&amp;A intrigue.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3218726\" data-linked=\"Speculation circulates on a Michael Kors-PVH merger of equals\" data-tweet=\"$PVH $PVH $CPRI - Speculation circulates on a Michael Kors-PVH merger of equals https://seekingalpha.com/news/3218726-speculation-circulates-on-michael-kors-pvh-merger-of-equals?source=tweet\" data-url=\"https://seekingalpha.com/news/3218726-speculation-circulates-on-michael-kors-pvh-merger-of-equals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218722\" data-ts=\"1477938818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SU\" target=\"_blank\">SU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218722-ontario-wind-power-assets-next-up-for-sale-suncor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ontario wind power assets next up for sale at Suncor</a></h4><ul>     <li>Suncor Energy (<a href='https://seekingalpha.com/symbol/SU' title='Suncor Energy Inc.'>SU</a> <font color='red'>-1.9%</font>) says it <a href=\"http://business.financialpost.com/news/energy/ontario-wind-power-assets-are-next-for-sale-after-suncor-sells-off-its-lubricants-business\" target=\"_blank\">plans to sell</a> all or parts of its Ontario wind power business following <a href=\"https://seekingalpha.com/news/3218554-hollyfrontier-buy-suncors-petro-canada-lubricants-unit-c-1_125b\" target=\"_blank\">today's sale</a> of its Petro-Canada lubricants business to HollyFrontier for $1.125B, but expects to hold onto its wind generation capacity in Alberta and Saskatchewan.</li>     <li>SU has said it plans to sell off $1.1B-$1.5B in assets, and is on pace to hit or exceed that target with the sale of its lubricants business, the recent sale of interests in oil storage facilities and the expected sale of the Ontario wind portfolio.</li><li>Raymond James analyst Chris Cox says the lubricants business generated US$150M in EBITDA for SU and that the company got fair value for the sale.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218722\" data-linked=\"Ontario wind power assets next up for sale at Suncor\" data-tweet=\"$SU - Ontario wind power assets next up for sale at Suncor https://seekingalpha.com/news/3218722-ontario-wind-power-assets-next-up-for-sale-suncor?source=tweet\" data-url=\"https://seekingalpha.com/news/3218722-ontario-wind-power-assets-next-up-for-sale-suncor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218718\" data-ts=\"1477937669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTL\" target=\"_blank\">CTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218718-centurylink-slides-12_8-on-level-3-deal-dividend-may-be-safer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CenturyLink slides 12.8% on Level 3 deal, but dividend may be safer</a></h4><ul>   <li>CenturyLink (<a href=\"https://seekingalpha.com/symbol/CTL\" title=\"CenturyLink, Inc.\">CTL</a> <font color=\"red\">-12.8%</font>) and Level 3 Communications (<a href=\"https://seekingalpha.com/symbol/LVLT\" title=\"Level 3 Communications, Inc.\">LVLT</a> <font color=\"green\">+4.3%</font>) have headed in opposite directions today after <a href=\"https://seekingalpha.com/news/3218527-centurylink-acquire-level-3-34b\" target=\"_blank\">confirmation of CenturyLink's $34B deal</a> to acquire the networking firm.</li>    <li>Level 3 has hung just off its 52-week high on the news, while CenturyLink is at its lowest point since February. The particulars of the deal -- a 49% premium to Level 3's closing last Wednesday -- may have CenturyLink's investors balking (the same folks who <font color=\"green\">bid CenturyLink up 9.7%</font> when early reports of a deal <a href=\"https://seekingalpha.com/news/3217676-centurylink-15-percent-level-3-6_5-percent-wsj-report-advanced-merger-talks\" target=\"_blank\">began to break last Thursday</a>).</li>    <li>Despite that big decline, the news may be <a href=\"http://blogs.barrons.com/incomeinvesting/2016/10/31/centurylink-falls-on-level-3-deal-but-dividend-may-be-more-secure/\" target=\"_blank\">good for CenturyLink's dividend</a>, which is likely more secure, argues Wells Fargo's Jennifer Fritzsche. \"Improved free cash flow will enhance the combined company's financial flexibility and significantly lower its payout ratio; CTL expects to maintain its annual dividend of $2.16 per share.\"</li>    <li>\"The increased scale afforded by the combined company is expected to generate $975 million of annual run-rate cash synergies, primarily from the elimination of duplicative functions, systems consolidation, and increased operational and capital efficiencies,\" Fritzsche writes.</li>\n<li>The combo should also benefit from almost $10B in net operating losses that Level 3 has.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218718\" data-linked=\"CenturyLink slides 12.8% on Level 3 deal, but dividend may be safer\" data-tweet=\"$CTL $CTL $LVLT - CenturyLink slides 12.8% on Level 3 deal, but dividend may be safer https://seekingalpha.com/news/3218718-centurylink-slides-12_8-on-level-3-deal-dividend-may-be-safer?source=tweet\" data-url=\"https://seekingalpha.com/news/3218718-centurylink-slides-12_8-on-level-3-deal-dividend-may-be-safer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218716\" data-ts=\"1477936851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218716-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/SNMX\" title=\"Senomyx, Inc.\">SNMX</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/AMTX\" title=\"Aemetis, Inc.\">AMTX</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/AHGP\" title=\"Alliance Holdings GP, L.P.\">AHGP</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/MBII\" title=\"Marrone Bio Innovations, Inc.\">MBII</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/ESES\" title=\"Eco-Stim Energy Solutions, Inc.\">ESES</a> <font color=\"green\">+6%</font>.</li> <li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/MEMP\" title=\"Memorial Production Partners LP\">MEMP</a> <font color=\"red\">-48%</font>. <a href=\"https://seekingalpha.com/symbol/EVEP-OLD\" title=\"EV Energy Partners, L.P.\">EVEP-OLD</a> <font color=\"red\">-18%</font>. <a href=\"https://seekingalpha.com/symbol/YUMA\" title=\"Yuma Energy, Inc.\">YUMA</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/MEP\" title=\"Midcoast Energy Partners, LP\">MEP</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/ORIG\" title=\"Ocean Rig UDW Inc.\">ORIG</a> <font color=\"red\">-13%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3218716\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$SNMX $AMTX $AHGP - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3218716-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3218716-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218711\" data-ts=\"1477934411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DECK\" target=\"_blank\">DECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218711-selling-pressure-on-deckers-outdoor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Selling pressure on Deckers Outdoor</a></h4><ul> <li>Deckers Outdoor (<a href=\"https://seekingalpha.com/symbol/DECK\" title=\"Deckers Outdoor Corporation\">DECK</a> <font color=\"red\">-4.3%</font>) is giving back some of its post-earnings gains today, although shares are still holding over $52.</li> <li>Several Wall Street firms still see considerable <a href=\"https://www.marketbeat.com/stocks/NYSE/DECK/\" target=\"_blank\">upside</a> on Deckers. Telsey Advisory Group has a price target of $72, while Canaccord Genuity's PT of $70 and Piper Jaffray's PT of $63 also show a positive outlook.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3217905-deckers-outdoor-beats-0_04-misses-revenue\" target=\"_blank\">Deckers Outdoor beats by $0.04, misses on revenue</a> (Oct. 27)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3218192-margins-hold-deckers-outdoor\" target=\"_blank\">Margins hold up at Deckers Outdoor</a> (Oct. 28)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3218711\" data-linked=\"Selling pressure on Deckers Outdoor\" data-tweet=\"$DECK - Selling pressure on Deckers Outdoor https://seekingalpha.com/news/3218711-selling-pressure-on-deckers-outdoor?source=tweet\" data-url=\"https://seekingalpha.com/news/3218711-selling-pressure-on-deckers-outdoor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218710\" data-ts=\"1477933810\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218710-porter-bancorp-higher-on-upgrade-thestreet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Porter Bancorp higher on upgrade by TheStreet</a></h4><ul>     <li>TheStreet upgrades Porter Bancorp (PBIB <font color='green'>+7.6%</font>) from hold to Buy after the company reported its quarterly <a href=\"https://seekingalpha.com/news/3217161-porter-bancorp-reports-q3-results\" target=\"_blank\">earnings</a> on 26th October.</li></ul><div class=\"tiny-share-widget\" data-id=\"3218710\" data-linked=\"Porter Bancorp higher on upgrade by TheStreet\" data-tweet=\"Porter Bancorp higher on upgrade by TheStreet https://seekingalpha.com/news/3218710-porter-bancorp-higher-on-upgrade-thestreet?source=tweet\" data-url=\"https://seekingalpha.com/news/3218710-porter-bancorp-higher-on-upgrade-thestreet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218706\" data-ts=\"1477933227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218706-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> PBIB <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/MCY' title='Mercury General Corporation'>MCY</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ESXB' title='Community Bankers Trust Corporation'>ESXB</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/L' title='Loews Corporation'>L</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CNA' title='CNA Financial Corporation'>CNA</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3218706\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$LMST $MCY $ESXB - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3218706-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3218706-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218707\" data-ts=\"1477933010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218707-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/INTX\" title=\"Intersections, Inc.\">INTX</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/BRCD\" title=\"Brocade Communications Systems, Inc.\">BRCD</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/MBRX\" title=\"Moleculin Biotech, Inc.\">MBRX</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/TMH\" title=\"Team Health Holdings, Inc.\">TMH</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/GAIA\" title=\"Gaia Inc.\">GAIA</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/AMTX\" title=\"Aemetis, Inc.\">AMTX</a> <font color=\"green\">+13%</font>. INCR <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/CDXS\" title=\"Codexis, Inc.\">CDXS</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/NTP\" title=\"Nam Tai Property Inc.\">NTP</a> <font color=\"green\">+10%</font>. PBIB <font color=\"green\">+8%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/MEMP\" title=\"Memorial Production Partners LP\">MEMP</a> <font color=\"red\">-50%</font>. OPXA <font color=\"red\">-29%</font>. SKLN <font color=\"red\">-21%</font>. <a href=\"https://seekingalpha.com/symbol/EVEP-OLD\" title=\"EV Energy Partners, L.P.\">EVEP-OLD</a> <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/YUMA\" title=\"Yuma Energy, Inc.\">YUMA</a> <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/LL\" title=\"Lumber Liquidators Holdings, Inc.\">LL</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/CGIX\" title=\"Cancer Genetics, Inc.\">CGIX</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/ZBH\" title=\"Zimmer Biomet Holdings, Inc.\">ZBH</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/CTL\" title=\"CenturyLink, Inc.\">CTL</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/NXTD\" title=\"NXT-ID Inc.\">NXTD</a> <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218707\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$INTX $BRCD $MBRX - Midday Gainers / Losers https://seekingalpha.com/news/3218707-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3218707-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218705\" data-ts=\"1477932573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COP\" target=\"_blank\">COP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218705-conocophillips-sells-senegal-oilfield-stakes-to-woodside-for-440m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ConocoPhillips sells Senegal oilfield stakes to Woodside for $440M</a></h4><ul>     <li>ConocoPhillips' (<a href=\"https://seekingalpha.com/symbol/COP\" title=\"ConocoPhillips\">COP</a> <font color=\"red\">-2.6%</font>) subsidiary in Senegal <a href=\"http://www.upi.com/Conoco-leaves-Senegalese-oil-behind/3731477905105/\" target=\"_blank\">agrees to sell</a> its 35% stake in three exploration areas to Woodside Petroleum (<a href=\"https://seekingalpha.com/symbol/WOPEF\" title=\"Woodside Petroleum Ltd.\">OTCPK:WOPEF</a>, <a href=\"https://seekingalpha.com/symbol/WOPEY\" title=\"Woodside Petroleum Ltd. ADR\">OTCPK:WOPEY</a>) for ~$350M.</li>     <li>COP says the appraisal and exploration phase went well but that the move is part of its strategy of prioritizing assets away from deepwater exploration efforts; meanwhile, Woodside moves into oil basins in the region that are considered one of the more lucrative prospects in West Africa.</li>     <li>The deal comes after COP's partner in the SNE deepwater oilfield, FAR Ltd., in August attempted to thwart a deal between COP and Woodside, claiming COP had breached their joint operating agreement.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218705\" data-linked=\"ConocoPhillips sells Senegal oilfield stakes to Woodside for $440M\" data-tweet=\"$COP $COP $WOPEF - ConocoPhillips sells Senegal oilfield stakes to Woodside for $440M https://seekingalpha.com/news/3218705-conocophillips-sells-senegal-oilfield-stakes-to-woodside-for-440m?source=tweet\" data-url=\"https://seekingalpha.com/news/3218705-conocophillips-sells-senegal-oilfield-stakes-to-woodside-for-440m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218702\" data-ts=\"1477932440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRCD\" target=\"_blank\">BRCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218702-bloomberg-brocade-near-deal-for-sale-shares-up-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Brocade near deal for sale; shares up 22%</a></h4><ul><li>The company is nearing the final stages of a sale process, according to the report, with Broadcom among the potential buyers. <a href=\"https://seekingalpha.com/symbol/BRCD\" title=\"Brocade Communications Systems, Inc.\">BRCD</a> <font color=\"green\">+22%</font>\n</li></ul><div class=\"tiny-share-widget\" data-id=\"3218702\" data-linked=\"Bloomberg: Brocade near deal for sale; shares up 22%\" data-tweet=\"$BRCD - Bloomberg: Brocade near deal for sale; shares up 22% https://seekingalpha.com/news/3218702-bloomberg-brocade-near-deal-for-sale-shares-up-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3218702-bloomberg-brocade-near-deal-for-sale-shares-up-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218697\" data-ts=\"1477931942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTB\" target=\"_blank\">CTB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218697-tire-stocks-take-turn-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tire stocks take a turn higher</a></h4><ul>\n<li>Shares of Cooper Tire &amp; Rubber (<a href=\"https://seekingalpha.com/symbol/CTB\" title=\"Cooper Tire &amp; Rubber Co.\">CTB</a> <font color=\"green\">+6.2%</font>) are higher after the company topped Q3 profit estimates. The rally has erased some losses piled up in front of the earnings release.</li>\n<li>An operating profit margin rate of over 15% in the Americas segment stood out during the quarter.</li>\n<li>Goodyear Tire &amp; Rubber (<a href=\"https://seekingalpha.com/symbol/GT\" title=\"Goodyear Tire &amp; Rubber Co.\">GT</a> <font color=\"green\">+2.3%</font>) is also solidly higher after the solid showing from Cooper.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3218541-cooper-tire-and-rubber-beats-0_03-misses-revenue\" target=\"_blank\">Cooper Tire &amp; Rubber beats by $0.03, misses on revenue</a> (Oct. 31)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3218593-cooper-tire-and-rubbers-q3\" target=\"_blank\">More on Cooper Tire &amp; Rubber's Q3</a> (Oct. 31)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218697\" data-linked=\"Tire stocks take a turn higher\" data-tweet=\"$CTB $CTB $GT - Tire stocks take a turn higher https://seekingalpha.com/news/3218697-tire-stocks-take-turn-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3218697-tire-stocks-take-turn-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218696\" data-ts=\"1477931914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIDU\" target=\"_blank\">BIDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218696-oppenheimer-co-raises-target-on-baidu-amid-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer &amp; Co. raises target on Baidu amid downgrades</a></h4><ul>\n<li>Despite post-earnings downgrades issued at <a href=\"https://seekingalpha.com/news/3218166-baidu-turns-higher-post-earnings-sell-side-bull-heads-sidelines\" target=\"_blank\">Credit Suisse</a> and <a href=\"http://www.benzinga.com/news/16/10/8622792/macquarie-downgrades-baidu-inc-american-depositary-shares-each-representing-one-t\" target=\"_blank\">Macquarie</a>, Jason Helfstein at Oppenheimer &amp; Co. <a href=\"http://blogs.barrons.com/techtraderdaily/2016/10/31/opco-raises-baidu-target-expects-search-to-recover/\" target=\"_blank\">reissues</a> an Outperform rating and raises Baidu's (<a href=\"https://seekingalpha.com/symbol/BIDU\" title=\"Baidu, Inc.\">BIDU</a> <font color=\"red\">-1.7%</font>) target from $188 to $200 (current price $177.18).</li>\n<li>Considers issues involving regulation near-term and forecasts search to recover despite a suggested bottom in Q4.</li>\n<li>Last week \u2013 <a href=\"https://seekingalpha.com/news/3218002-baidu-1_6-percent-lower-hours-revenue-nominally-greater-decline-projected-q4\" target=\"_blank\">Baidu 1.6% lower after hours; revenue down nominally, greater decline projected for Q4</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218696\" data-linked=\"Oppenheimer &amp; Co. raises target on Baidu amid downgrades\" data-tweet=\"$BIDU - Oppenheimer &amp; Co. raises target on Baidu amid downgrades https://seekingalpha.com/news/3218696-oppenheimer-co-raises-target-on-baidu-amid-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3218696-oppenheimer-co-raises-target-on-baidu-amid-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218689\" data-ts=\"1477931159\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARTH\" target=\"_blank\">ARTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218689-arch-therapeutics-ac5-topical-hemostatic-device-effective-in-patients-on-antiplatelet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arch Therapeutics AC5 Topical Hemostatic Device effective in patients on antiplatelet medication; shares up 8%</a></h4><ul>\n<li>Thinly traded nano cap Arch Therapeutics (<a href=\"https://seekingalpha.com/symbol/ARTH\" title=\"Arch Therapeutics, Inc.\">OTCQB:ARTH</a> <font color=\"green\">+8.2%</font>) moves up on a 50% surge in volume in response to its announcement of additional positive data from a <a href=\"https://seekingalpha.com/news/3203318-arch-therapeutics-hemostatic-candidate-ac5-effective-early-stage-study-shares-6-percent\" target=\"_blank\">previously reported study</a> assessing its AC5 Topical Hemostatic Device in skin lesion patients with bleeding wounds.</li>\n<li>In a subgroup of 10 patients on antiplatelet therapy, the median shortened time to hemostasis (TTH) after treatment with AC5 was less than 30 seconds, the same TTH as the overall study group of 46 patients.</li>\n<li>\n<a href=\"http://www.archtherapeutics.com/product/product\" target=\"_blank\">AC5 </a>is a synthetic peptide comprised of naturally occurring amino acids. When sprayed onto a wound, it incorporates into the connective tissue forming a barrier to leaking substances, including blood and other body fluids, regardless of clotting ability.</li>\n<li>The company intends to submit the data for publication and to include it in its regulatory filings, including its application for CE Mark slated for late Q4/early Q1. Plans are in process for further development in the U.S. and EU.</li>\n<li>Read now <a href=\"https://seekingalpha.com/article/4000061-arch-therapeutics-seals-deal-strong-trial-data-ac5-hemostatic-device\" target=\"_blank\">Arch Therapeutics Seals The Deal On Strong Trial Data For Its AC5 Hemostatic Device </a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218689\" data-linked=\"Arch Therapeutics AC5 Topical Hemostatic Device effective in patients on antiplatelet medication; shares up 8%\" data-tweet=\"$ARTH - Arch Therapeutics AC5 Topical Hemostatic Device effective in patients on antiplatelet medication; shares up 8% https://seekingalpha.com/news/3218689-arch-therapeutics-ac5-topical-hemostatic-device-effective-in-patients-on-antiplatelet?source=tweet\" data-url=\"https://seekingalpha.com/news/3218689-arch-therapeutics-ac5-topical-hemostatic-device-effective-in-patients-on-antiplatelet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218687\" data-ts=\"1477930003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/L\" target=\"_blank\">L</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218687-loews-on-move-after-blasting-through-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Loews on the move after blasting through estimates</a></h4><ul>\n<li>Q3 net income of $327M or $0.97 per share vs. $182M and $0.50 one year ago. Income before investment gains of $300M vs. $211M. Investment gains of $27M vs. a loss of $29M.</li>\n<li>Book value per share of $54.22 up from $51.67 at the start of the year. Excluding AOCI, BVPS of $53.79 up from $52.72. Current price after today's gain is $43.39.</li>\n<li>CNA Financial saw higher net investment income as well as realized investment gains. Diamond Offshore saw earnings decline thanks to a big drop in operating rigs vs. a year ago. Excluding a tax refund from last year, Boardwalk Pipeline had better results, and Loews Hotels' earnings increased thanks to income from JV properties.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/L\" title=\"Loews Corporation\">L</a> <font color=\"green\">+5.8%</font> to $43.40.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3218504-loews-beats-0_28\" target=\"_blank\">Loews beats by $0.28</a> (Oct. 31)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218687\" data-linked=\"Loews on the move after blasting through estimates\" data-tweet=\"$L - Loews on the move after blasting through estimates https://seekingalpha.com/news/3218687-loews-on-move-after-blasting-through-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3218687-loews-on-move-after-blasting-through-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218686\" data-ts=\"1477929670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218686-consumer-goods-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/STS\" title=\"Supreme Industries, Inc\">STS</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/JBSS\" title=\"John B. Sanfilippo &amp; Son, Inc.\">JBSS</a> <font color=\"green\">+7%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/JCI\" title=\"Johnson Controls International plc\">JCI</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/GPRO\" title=\"GoPro\">GPRO</a> <font color=\"red\">-6%</font>. <a href=\"https://seekingalpha.com/symbol/NVFY\" title=\"Nova Lifestyle, Inc.\">NVFY</a> <font color=\"red\">-6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218686\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$STS $JBSS $JCI - Consumer Goods - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3218686-consumer-goods-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3218686-consumer-goods-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218682\" data-ts=\"1477929547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAH\" target=\"_blank\">CAH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218682-cardinal-health-fq1-top-line-up-14-non-gaap-eps-down-10-cash-flow-ops-up-200-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cardinal Health FQ1 top line up 14%; non-GAAP EPS down 10%; cash flow ops up 200%; shares up 5%</a></h4><ul>\n<li>Cardinal Health (<a href=\"https://seekingalpha.com/symbol/CAH\" title=\"Cardinal Health Inc.\">CAH</a> <font color=\"green\">+4.6%</font>) fiscal Q1 results ($M): Revenue: 32,039 (+14.2%); Pharmaceutical: 28,762 (+14.4%).</li>\n<li>Net Income: 309 (-19.3%); Non-GAAP Net Income: 399 (-12.9%); EPS: 0.96 (-16.5%); Non-GAAP EPS: 1.24 (-10.1%); CF Ops: 104 (+200.0%).</li>\n<li>Consensus view was EPS of $1.21 on revenues of $31.0B.</li>\n<li>\n<strong>Fiscal 2017 Guidance</strong>: Pharmaceutical segment profit: mid-to-high-single-digit drop; Non-GAAP EPS: $5.40 - 5.60 from $5.48 - 5.73.</li>\n<li>Shares are up despite comments from management that the near-term environment is \"challenging\" with public debate on drug pricing weighing on generic as well as branded meds. The company says it does not need to price below the market to compete effectively. It is also on the lookout for attractive acquisition targets but will remain disciplined in its approach.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218682\" data-linked=\"Cardinal Health FQ1 top line up 14%; non-GAAP EPS down 10%; cash flow ops up 200%; shares up 5%\" data-tweet=\"$CAH - Cardinal Health FQ1 top line up 14%; non-GAAP EPS down 10%; cash flow ops up 200%; shares up 5% https://seekingalpha.com/news/3218682-cardinal-health-fq1-top-line-up-14-non-gaap-eps-down-10-cash-flow-ops-up-200-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3218682-cardinal-health-fq1-top-line-up-14-non-gaap-eps-down-10-cash-flow-ops-up-200-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218683\" data-ts=\"1477929377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WETF\" target=\"_blank\">WETF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218683-citi-wisdomtree-fall-another-27\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi: WisdomTree could fall another 27%</a></h4><ul>\n<li>WisdomTree (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WETF\" title=\"WisdomTree Investments, Inc.\">WETF</a>) on Friday added to already steep year-to-date declines <a href=\"https://seekingalpha.com/news/3218146-outflows-continue-wisdomtree\" target=\"_blank\">after reporting an</a> inline quarter, but a continued draw on AUM.</li>\n<li>While Citi's William Katz isn't so bearish as to keep the stock on his bank's Focus List, <a href=\"http://blogs.barrons.com/focusonfunds/2016/10/31/a-grinding-decline-ahead-for-wisdometree/?mod=BOL_hp_blog_fof\" target=\"_blank\">he remains a seller with </a>a $6.50 price target, noting in particular, the current 40x earnings multiple when others like BlackRock and Invesco are generating more ETF volumes at cheaper valuations. Further, the $0.08 per share quarterly dividend is at risk, and the merger math doesn't add up.</li>\n<li>Shares are<font color=\"red\"> lower by another 3.15%</font> today to $8.75.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218683\" data-linked=\"Citi: WisdomTree could fall another 27%\" data-tweet=\"$WETF - Citi: WisdomTree could fall another 27% https://seekingalpha.com/news/3218683-citi-wisdomtree-fall-another-27?source=tweet\" data-url=\"https://seekingalpha.com/news/3218683-citi-wisdomtree-fall-another-27\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218680\" data-ts=\"1477928283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPP\" target=\"_blank\">WPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218680-wppplus-4_5-making-hay-from-falling-pound-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WPP +4.5%, making hay from falling pound in Q3</a></h4><ul>   <li>A falling pound meant strength for ad giant WPP (WPPGY), <font color=\"green\">up 4.5%</font> after revenues <a href=\"https://seekingalpha.com/news/3218548-wpp-plc-reports-q3-results\" target=\"_blank\">rose 23% in Q3</a> even as UK clients began to hold back spending in the wake of Britain's vote to exit the EU.</li>    <li>\"Geographically, like-for-like revenue growth in the third quarter was slightly stronger in North America, but softer in the United Kingdom (perhaps reflecting the first impact of Brexit uncertainties) and continued at similarly strong levels in Western Continental Europe in comparison to the second quarter,\" it said.</li>    <li>Overall, like-for-like revenue growth was 3.2% and net sales growth was 2.8%.</li>    <li>The company will do a formal review of its forecasts in the next two weeks, but is guiding to full-year revenue (like-for-like) and net sales growth of more than 3%, with the gap between revenue and net sales growth shrinking further. It sees headline net sales operating margin improvement of 0.3 points in constant currency (with reportable margins even stronger).</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3218680\" data-linked=\"WPP +4.5%, making hay from falling pound in Q3\" data-tweet=\"$WPP $WPPGF - WPP +4.5%, making hay from falling pound in Q3 https://seekingalpha.com/news/3218680-wppplus-4_5-making-hay-from-falling-pound-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3218680-wppplus-4_5-making-hay-from-falling-pound-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218679\" data-ts=\"1477928222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSA\" target=\"_blank\">PSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218679-public-storage-pulls-out-of-slide-goldman-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Public Storage pulls out of slide as Goldman upgrades</a></h4><ul>\n<li>Is the bottom in yet for self-storage REITs? The previously favored group has been in a sizable slide since April, with sector giant Public Storage (NYSE:<a href=\"https://seekingalpha.com/symbol/PSA\" title=\"Public Storage\">PSA</a>) leading the way with about a <font color=\"red\">25% drop</font>.</li>\n<li>\"Two factors support the view that PSA\u2019s same store growth deceleration is near over,\" says Goldman's Andrew Rosivach, <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/10/8623340/public-storage-gets-a-boost-as-goldman-sachs-removed-co-\" target=\"_blank\">upgrading to Neutral from Sell</a>. First, trailing 12-month employment growth - highly correlated to PSA same-store revenue growth - has ceased declining for five straight months. Second, the company's period-end rent and occupancy levels are slowing less.</li>\n<li>He also sees Public Storage's growth surpassing that of its REIT peers by an average of 1.7% in 2017.</li>\n<li>The $220 price target compares to the current $207.75, and is based on a target 2019 AFFO multiple of 19.4x - a 10% premium to the sector.</li>\n<li>PSA <font color=\"green\">+1.1%</font> on today's session.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218679\" data-linked=\"Public Storage pulls out of slide as Goldman upgrades\" data-tweet=\"$PSA - Public Storage pulls out of slide as Goldman upgrades https://seekingalpha.com/news/3218679-public-storage-pulls-out-of-slide-goldman-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3218679-public-storage-pulls-out-of-slide-goldman-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218677\" data-ts=\"1477928219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218677-shire-eases-3-on-express-scripts-comments-on-corralling-rising-costs-of-hemophilia-meds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shire eases 3% on Express Scripts comments on corralling rising costs of hemophilia meds</a></h4><ul>\n<li>Shire plc (<a href=\"https://seekingalpha.com/symbol/SHPG\" title=\"Shire PLC\">SHPG</a> <font color=\"red\">-3.3%</font>) slumps in early trading on increased volume in apparent response to comments made by Express Scripts (<a href=\"https://seekingalpha.com/symbol/ESRX\" title=\"Express Scripts, Inc.\">ESRX</a> <font color=\"green\">+2.6%</font>) Chief Medical Officer Steven Miller during a phone interview. He said the company is mulling ways to manage the rising costs of hemophilia medicines without forcing patients to switch treatments. Shire is a major player in the space after its merger with Baxalta. Hemophilia products accounted for over 46% of Baxalta's business in 2015.</li>\n<li>Related tickers: (<a href=\"https://seekingalpha.com/symbol/BAYRY\" title=\"Bayer A.G. ADR\">OTCPK:BAYRY</a> <font color=\"red\">-0.7%</font>)(<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a> <font color=\"red\">-0.2%</font>)(<a href=\"https://seekingalpha.com/symbol/NVO\" title=\"Novo Nordisk A/S\">NVO</a> <font color=\"red\">-0.4%</font>)(<a href=\"https://seekingalpha.com/symbol/BMRN\" title=\"BioMarin Pharmaceutical Inc.\">BMRN</a> <font color=\"red\">-0.6%</font>)(<a href=\"https://seekingalpha.com/symbol/BAX\" title=\"Baxter International Inc\">BAX</a> <font color=\"green\">+0.9%</font>)(<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> <font color=\"red\">-0.4%</font>)(<a href=\"https://seekingalpha.com/symbol/SGMO\" title=\"Sangamo Therapeutics, Inc.\">SGMO</a> <font color=\"green\">+1.4%</font>)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218677\" data-linked=\"Shire eases 3% on Express Scripts comments on corralling rising costs of hemophilia meds\" data-tweet=\"$SHPG $SHPG $ESRX - Shire eases 3% on Express Scripts comments on corralling rising costs of hemophilia meds https://seekingalpha.com/news/3218677-shire-eases-3-on-express-scripts-comments-on-corralling-rising-costs-of-hemophilia-meds?source=tweet\" data-url=\"https://seekingalpha.com/news/3218677-shire-eases-3-on-express-scripts-comments-on-corralling-rising-costs-of-hemophilia-meds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218678\" data-ts=\"1477927693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHGE\" target=\"_blank\">BHGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218678-baker-hughes-slumps-nearly-3-analysts-see-no-premium-in-ge-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baker Hughes slumps nearly 3% as analysts see no premium in GE deal</a></h4><ul>     <li>Baker Hughes (BHI <font color=\"red\">-2.8%</font>) shares slump to their lowest of the day after jumping by as much as 6% in the premarket, as Jefferies analysts contend that a \u201cquick valuation suggests <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/10/31/baker-hughes-wheres-the-takeover-premium/\" target=\"_blank\">no premium</a> in the General Electric-Baker Hughes combination without synergies... in other words, the deal excluding synergies appears to be paying current market value.\"</li>     <li>Jefferies says it calculated a $24B enterprise value for BHI shareholders in the <a href=\"https://seekingalpha.com/news/3218658-baker-hughes-ge-shares-head-opposite-directions-deal-sinks\" target=\"_blank\">GE deal</a> based on consensus estimated 2017 EBITDA, suggesting no premium without synergies and assuming no dispositions, adding that a lack of premium is not particularly surprising as the opportunity will be \"sold\u201d based on cost and revenue synergies.</li>     <li>The firm says the $1.6B cost synergies target is surprising based on the $500M in synergies in the Schlumberger-Cameron combination.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218678\" data-linked=\"Baker Hughes slumps nearly 3% as analysts see no premium in GE deal\" data-tweet=\"$BHGE $BKR - Baker Hughes slumps nearly 3% as analysts see no premium in GE deal https://seekingalpha.com/news/3218678-baker-hughes-slumps-nearly-3-analysts-see-no-premium-in-ge-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3218678-baker-hughes-slumps-nearly-3-analysts-see-no-premium-in-ge-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218663\" data-ts=\"1477926773\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAPR\" target=\"_blank\">CAPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218663-capricors-lead-product-candidate-shows-mixed-results-in-early-stage-heart-failure-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capricor&#39;s lead product candidate shows mixed results in early-stage heart failure study; shares off 2%</a></h4><ul>\n<li>Results from a Phase 1 study, DYNAMIC, assessing Capricor Therapeutics' (<a href=\"https://seekingalpha.com/symbol/CAPR\" title=\"Capricor Therapeutics, Inc.\">CAPR</a> <font color=\"red\">-1.8%</font>) lead product candidate CAP-1002 in patients with advance heart failure showed an uneven treatment effect. The data were presented the annual scientific symposium of the Cardiovascular Research Foundation called the 28th Transcatheter Cardiovascular Therapeutics in Washington, D.C.</li>\n<li>\n<a href=\"https://clinicaltrials.gov/ct2/show/NCT02293603?term=CAP-1002&amp;rank=2\" target=\"_blank\">DYNAMIC </a>enrolled 14 patients with New York Heart Association (NYHA) Class III heart failure secondary to dilated cardiomyopathy and who demonstrated a left ventricular ejection fraction (LVEF) of no more than 35% (55% or more is considered normal) despite the maximum level of medical and device-base therapy. Subjects received a single administration of CAP-1002 (37.5M, 50.0M, 62.5M or 75M cells) infused directly into the three major coronary arteries and then followed for 12 months.</li>\n<li>Efficacy was evaluated at Month 6 and Month 12. Results for the individual doses were not disclosed. On a pooled basis, statistically valid improvements were observed in NYHA class, LVEF and a quality-of-life questionnaire called MLHFQ. At Month 12, the improvement in LVEF was maintained, but three other heart performance measures fell short of statistical significance. Patients who received the 75M-cell dose (n=5) was the only group where all showed improvement. At Month 6, three improved to Class II status and two to Class 1. At Month 12, two were Class II and three were Class 1, showing a durable treatment effect.</li>\n<li>CAP-1002 was well-tolerated with no events recorded for the primary safety endpoint, a composite of five cardiac event types.</li>\n<li>\n<a href=\"http://capricor.com/product-pipeline/cap-1002/\" target=\"_blank\">CAP-1002</a> is an investigational allogeneic, off-the-shelf cardiac cell therapy derived from donor heart tissue and infused directly into the patients coronary artery via a catheter. It is currently being evaluated for the treatment of heart disease associated with Duchenne muscular dystrophy and myocardial infarction (heart attack).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218663\" data-linked=\"Capricor&#39;s lead product candidate shows mixed results in early-stage heart failure study; shares off 2%\" data-tweet=\"$CAPR - Capricor&#39;s lead product candidate shows mixed results in early-stage heart failure study; shares off 2% https://seekingalpha.com/news/3218663-capricors-lead-product-candidate-shows-mixed-results-in-early-stage-heart-failure-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3218663-capricors-lead-product-candidate-shows-mixed-results-in-early-stage-heart-failure-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218665\" data-ts=\"1477926051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218665-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/PMD' title='Psychemedics Corporation'>PMD</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/APHB' title='AmpliPhi Biosciences Corp.'>APHB</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/DVA' title='DaVita HealthCare Partners Inc.'>DVA</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> OPXA <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/ZBH' title='Zimmer Biomet Holdings, Inc.'>ZBH</a> <font color='red'>-14%</font>. SKLN <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals'>EYEG</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CRBP' title='Corbus Pharmaceuticals Holdings, Inc.'>CRBP</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3218665\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$MBRX $PMD $ARMP - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3218665-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3218665-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218667\" data-ts=\"1477925765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFE\" target=\"_blank\">SFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218667-safeguard-scientifics-defended-after-disappointing-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Safeguard Scientifics defended after disappointing quarter</a></h4><ul>\n<li>The company had a rough end to last week <a href=\"https://seekingalpha.com/news/3217296-safeguard-scientifics-misses-0_44\" target=\"_blank\">after missing analyst estimates</a> for Q3, but Ascendiant Capital's Edward Woo remains a fan, reiterating his Buy rating and $18 price target (<font color=\"green\">57% upside</font>).</li>\n<li>He notes last quarter's divestiture of Putney for $200M resulted in cash proceeds of $58M to Safeguard (NYSE:<a href=\"https://seekingalpha.com/symbol/SFE\" title=\"Safeguard Scientifics, Inc.\">SFE</a>) for about a 4x cash-on-cash return. The success of this sale implies more big profitable exits, says Woo, though these could be pushed into 2017.</li>\n<li>Safeguard ended the quarter with $77M in cash and $52M in debt, or about $1 per share in net cash, giving it the firepower to make future investments, says Woo.</li>\n<li>While Safeguard trades at a healthy premium to book value per share of $8.09, Woo reminds it does not utilize Fair Value accounting, so most of its investments are booked at a cost- or worst-basis valuation.</li>\n<li>Shares are <font color=\"red\">lower by another 2.6%</font> today.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218667\" data-linked=\"Safeguard Scientifics defended after disappointing quarter\" data-tweet=\"$SFE - Safeguard Scientifics defended after disappointing quarter https://seekingalpha.com/news/3218667-safeguard-scientifics-defended-after-disappointing-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3218667-safeguard-scientifics-defended-after-disappointing-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218662\" data-ts=\"1477925069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEL\" target=\"_blank\">CEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218662-cellcomplus-2_5-after-getting-antitrust-ok-for-xfone-sharing-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellcom +2.5% after getting antitrust OK for Xfone sharing deal</a></h4><ul>    <li>Cellcom (<a href=\"https://seekingalpha.com/symbol/CEL\" title=\"Cellcom Israel, Ltd.\">CEL</a> <font color=\"green\">+2.5%</font>) has won an OK from Israel's Antitrust commissioner for its network sharing and hosting agreement (and other negotiations) with Marathon 018 Xfone.</li>    <li>The approval is subject to annulment of one provision, and the arrangement still requires an OK from the Ministry of Communications.</li>    <li>Meanwhile over the weekend, the company announced that it's brought its TV services to more than 100,000 households, which \"chose Cellcom TV and enjoy quality and advanced TV, rich and diverse content, dozens of channels and all for the best price in Israel,\" said CEO Nir Sztern. \"The TV market revolution is at its peak and this is only the beginning.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218662\" data-linked=\"Cellcom +2.5% after getting antitrust OK for Xfone sharing deal\" data-tweet=\"$CEL - Cellcom +2.5% after getting antitrust OK for Xfone sharing deal https://seekingalpha.com/news/3218662-cellcomplus-2_5-after-getting-antitrust-ok-for-xfone-sharing-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3218662-cellcomplus-2_5-after-getting-antitrust-ok-for-xfone-sharing-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218655\" data-ts=\"1477924475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCLR\" target=\"_blank\">OCLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218655-needham-company-remains-firmly-positive-on-optical-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham &amp; Company remains firmly positive on optical sector</a></h4><ul>\n<li>Alex Henderson recommends Oclaro (<a href=\"https://seekingalpha.com/symbol/OCLR\" title=\"Oclaro, Inc.\">OCLR</a> <font color=\"green\">+1.5%</font>), NeoPhotonics (<a href=\"https://seekingalpha.com/symbol/NPTN\" title=\"NeoPhotonics Corporation\">NPTN</a> <font color=\"green\">+1.9%</font>), Lumentum Holdings (<a href=\"https://seekingalpha.com/symbol/LITE\" title=\"Lumentum Holdings Inc.\">LITE</a> <font color=\"red\">-2.5%</font>), Fabrinet (<a href=\"https://seekingalpha.com/symbol/FN\" title=\"Fabrinet\">FN</a> <font color=\"green\">+0.9%</font>), Finisar (<a href=\"https://seekingalpha.com/symbol/FNSR\" title=\"Finisar Corporation\">FNSR</a> <font color=\"green\">+0.3%</font>), Inphi (<a href=\"https://seekingalpha.com/symbol/IPHI\" title=\"Inphi Corporation\">IPHI</a> <font color=\"red\">-0.1%</font>), II-VI (<a href=\"https://seekingalpha.com/symbol/IIVI\" title=\"II-VI Incorporated\">IIVI</a> <font color=\"green\">+1.8%</font>), GigPeak (<a href=\"https://seekingalpha.com/symbol/GIG\" title=\"GigPeak, Inc.\">GIG</a>) and M/A-COM Technology Solutions Holdings (<a href=\"https://seekingalpha.com/symbol/MTSI\" title=\"MACOM Technology Solutions Holdings, Inc.\">MTSI</a> <font color=\"green\">+0.5%</font>) despite <a href=\"https://seekingalpha.com/news/3217650-opticals-dim-sector-watch\" target=\"_blank\">recent pullback</a> in the sector.</li>\n<li>On Acacia Communications (<a href=\"https://seekingalpha.com/symbol/ACIA\" title=\"Acacia Communications\">ACIA</a> <font color=\"green\">+0.2%</font>), considers \"overcorrected\" and sees a reversal in movement on projected strong Q4 guidance and 2017 upside.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218655\" data-linked=\"Needham &amp; Company remains firmly positive on optical sector\" data-tweet=\"$OCLR $OCLR $NPTN - Needham &amp; Company remains firmly positive on optical sector https://seekingalpha.com/news/3218655-needham-company-remains-firmly-positive-on-optical-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3218655-needham-company-remains-firmly-positive-on-optical-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218652\" data-ts=\"1477923390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218652-deere-advances-on-baird-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere advances on Baird upgrade</a></h4><ul>\n<li>Deere (<a href=\"https://seekingalpha.com/symbol/DE\" title=\"Deere &amp; Company\">DE</a> <font color=\"green\">+1.6%</font>) begins the week on a positive note after Baird <a href=\"https://www.thestreet.com/story/13873413/1/deere-de-stock-advances-baird-upgrades.html\" target=\"_blank\">upgraded</a> the stock to Outperform from Neutral with a price target of $100.</li>\n<li>There are signs of emerging demand outside the U.S. as pricing of North American large agricultural equipment is back to multi-decade lows, according to the firm, which stated Deere also has meaningful cost savings in its pipeline.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218652\" data-linked=\"Deere advances on Baird upgrade\" data-tweet=\"$DE - Deere advances on Baird upgrade https://seekingalpha.com/news/3218652-deere-advances-on-baird-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3218652-deere-advances-on-baird-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218644\" data-ts=\"1477922257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218644-treasury-prices-rise-after-disappointing-chicago-pmi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Treasury prices rise after disappointing Chicago PMI</a></h4><ul>\n<li>The Chicago PMI<a href=\"https://s3.amazonaws.com/images.chaptermanager.com/chapters/b742ccc3-ff70-8eca-4cf5-ab93a6c8ab97/files/mni-chicago-press-release-2016-10-1477921736359.pdf\" target=\"_blank\"> unexpectedly fell 3.6 points</a> in October to a five-month low of 50.6%. Expectations had been for about a flat read from September. The three-month moving average dipped to 52.1 from 53.8.</li>\n<li>Leading the decline was a 5.4 drop in Production to 54.4, and New Orders fell to their weakest since May. Backlogs increased slightly, but remained in contraction territory. Employment also rose a bit, just climbing into the expansion zone. Supplier Deliveries fell to its weakest since June.</li>\n<li>Alongside the slowdown in activity, inflation perked up, with Prices Paid jumping to its highest level since November 2014.</li>\n<li>The 10-year Treasury yield is down two basis pints to 1.833%. <a href=\"https://seekingalpha.com/symbol/TLT\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a> <font color=\"green\">+0.4%</font>, <a href=\"https://seekingalpha.com/symbol/TBT\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a> <font color=\"red\">-0.8%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218644\" data-linked=\"Treasury prices rise after disappointing Chicago PMI\" data-tweet=\"$TLT $TBT - Treasury prices rise after disappointing Chicago PMI https://seekingalpha.com/news/3218644-treasury-prices-rise-after-disappointing-chicago-pmi?source=tweet\" data-url=\"https://seekingalpha.com/news/3218644-treasury-prices-rise-after-disappointing-chicago-pmi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218639\" data-ts=\"1477921659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBT\" target=\"_blank\">MBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218639-mobile-telesystemsplus-3_4-on-minority-buyback-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mobile TeleSystems +3.4% on minority buyback plan</a></h4><ul>   <li>Mobile TeleSystems (NYSE:<a href=\"https://seekingalpha.com/symbol/MBT\" title=\"Mobile TeleSystems\">MBT</a>) is <font color=\"green\">up 3.4%</font> after announcing a plan to buy back shares from minority holders.</li>    <li>Minority holders will be able to tender shares in a modified Dutch auction before Dec. 1 (or Nov. 30 in the case of MTS ADRs) for a price range of 199-229 rubles/share -- a price range running from a discount of 9.2% to a premium of 4.5%, Morgan Stanley notes.</li>    <li>And then MTS will buy up to 24,796,619 shares (1.24% of issued), maxing out at 4.9B rubles (about $77.4M) returned to shareholders.</li>    <li>MTS unit Stream Digital will act as offeror, and after completion of the offer, core MTS shareholder Sistema (with 50.65% of the company) will be able to sell its shares on a pro rata basis; it's not selling into the tender offer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218639\" data-linked=\"Mobile TeleSystems +3.4% on minority buyback plan\" data-tweet=\"$MBT - Mobile TeleSystems +3.4% on minority buyback plan https://seekingalpha.com/news/3218639-mobile-telesystemsplus-3_4-on-minority-buyback-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3218639-mobile-telesystemsplus-3_4-on-minority-buyback-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218632\" data-ts=\"1477920428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLT\" target=\"_blank\">HLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218632-hilton-worldwide-sparked-barrons-mention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hilton Worldwide sparked by Barron&#39;s mention</a></h4><ul> <li>Hilton Worldwide (NYSE:<a href=\"https://seekingalpha.com/symbol/HLT\" title=\"Hilton Worldwide Holdings\">HLT</a>) is tracking higher in early trading after the stock is mentioned <a href=\"http://www.barrons.com/articles/hiltons-breakup-could-boost-value-by-25-1477715696\" target=\"_blank\">favorably</a> in Barron's.</li> <li>The three-way split of the hotel operator is seen providing investors with 25% upside potential.</li> <li>Hilton trades with a PE ratio of 14.22.</li> <li>HLT <font color=\"green\">+2.79%</font> premarket to $22.87.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3218632\" data-linked=\"Hilton Worldwide sparked by Barron&#39;s mention\" data-tweet=\"$HLT - Hilton Worldwide sparked by Barron&#39;s mention https://seekingalpha.com/news/3218632-hilton-worldwide-sparked-barrons-mention?source=tweet\" data-url=\"https://seekingalpha.com/news/3218632-hilton-worldwide-sparked-barrons-mention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218631\" data-ts=\"1477920394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTLF\" target=\"_blank\">HTLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218631-heartland-financial-agrees-to-buy-founders-bancorp-in-29_1m-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heartland Financial agrees to buy Founders Bancorp in $29.1M deal</a></h4><ul>\n<li>Iowa-based Heartland Financial (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HTLF\" title=\"Heartland Financial USA, Inc.\">HTLF</a>) scoops up San Luis Obispo, CA-based Founders Bancorp (<a href=\"https://seekingalpha.com/symbol/FBCP\" title=\"Founders Bancorp\">OTCPK:FBCP</a>) in a stock/cash deal valued at $21.87 per share, a <font color=\"green\">63.5% premium</font> to the most recent close.</li>\n<li>At the close, Founders will be merged into Heartland's CA-based subsidiary, Premier Valley Bank (<a href=\"https://seekingalpha.com/symbol/PVLY\" title=\"Premier Valley Bank (Fresno, CA)\">OTCPK:PVLY</a>).</li>\n<li>The deal is expected to close in Q1 of 2017.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218631\" data-linked=\"Heartland Financial agrees to buy Founders Bancorp in $29.1M deal\" data-tweet=\"$HTLF $HTLF $FBCP - Heartland Financial agrees to buy Founders Bancorp in $29.1M deal https://seekingalpha.com/news/3218631-heartland-financial-agrees-to-buy-founders-bancorp-in-29_1m-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3218631-heartland-financial-agrees-to-buy-founders-bancorp-in-29_1m-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218629\" data-ts=\"1477920125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218629-constellation-brands-buys-mexico-brewery-from-b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Constellation Brands buys Mexico brewery from A-B</a></h4><ul>     <li>Constellations Brands (NYSE:<a href=\"https://seekingalpha.com/symbol/STZ\" title=\"Constellation Brands, Inc.\">STZ</a>) announces it acquired Obregon Brewery from Grupo Modelo for $600M.</li>     <li>The deal has to be approved by the DOJ before closing.</li>     <li>The plant located in Mexico is expected to have 4M hectoliters of production capacity with minimal investment.</li>     <li>\"We believe this is the right strategy to provide near-term capacity and greater flexibility to support our growth and innovation plans, while allowing for the buildout of our Mexicali brewery over an extended time period,\" says Constellation CEO Rob Sands.</li>     <li>Grupo Modelo is a subsidiary of Anheuser-Busch InBev (NYSE:<a href=\"https://seekingalpha.com/symbol/BUD\" title=\"Anheuser-Busch InBev SA/NV\">BUD</a>).</li>     <li>STZ <font color=\"green\">+1.12%</font> premarket to $167.88.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218629\" data-linked=\"Constellation Brands buys Mexico brewery from A-B\" data-tweet=\"$STZ $STZ $BUD - Constellation Brands buys Mexico brewery from A-B https://seekingalpha.com/news/3218629-constellation-brands-buys-mexico-brewery-from-b?source=tweet\" data-url=\"https://seekingalpha.com/news/3218629-constellation-brands-buys-mexico-brewery-from-b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218627\" data-ts=\"1477919981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218627-premarket-gainers-losers-of-9-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:15 am</a></h4><ul> <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/TMH\" title=\"Team Health Holdings, Inc.\">TMH</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/SNMX\" title=\"Senomyx, Inc.\">SNMX</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/CIDM\" title=\"Cinedigm Corp.\">CIDM</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/SAEX\" title=\"SAExploration Holdings, Inc.\">SAEX</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a> <font color=\"green\">+6%</font>. BHI <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/EURN\" title=\"Euronav NV\">EURN</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/LVLT\" title=\"Level 3 Communications, Inc.\">LVLT</a> <font color=\"green\">+5%</font>.</li> <li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/MEMP\" title=\"Memorial Production Partners LP\">MEMP</a> <font color=\"red\">-38%</font>. <a href=\"https://seekingalpha.com/symbol/ZBH\" title=\"Zimmer Biomet Holdings, Inc.\">ZBH</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/CTL\" title=\"CenturyLink, Inc.\">CTL</a> <font color=\"red\">-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3218627\" data-linked=\"Premarket Gainers / Losers as of 9:15 am\" data-tweet=\"$TMH $SNMX $CIDM - Premarket Gainers / Losers as of 9:15 am https://seekingalpha.com/news/3218627-premarket-gainers-losers-of-9-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3218627-premarket-gainers-losers-of-9-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218625\" data-ts=\"1477919897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVN\" target=\"_blank\">INVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218625-invensense-hires-advisor-to-evaluate-interestplus-5_88-pre-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InvenSense hires advisor to evaluate interest; +5.88% pre-market</a></h4><ul>\n<li>InvenSense (NYSE:<a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a>) formally notes it has received significant attention and that an exploration of strategic options is ongoing.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/3218396-invensense-plus-11-percent-exploration-strategic-alternatives-reported\" target=\"_blank\">Reports</a> the company was moving in this direction first surfaced Friday, with shares now <font color=\"green\">17%</font> higher from that point.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218625\" data-linked=\"InvenSense hires advisor to evaluate interest; +5.88% pre-market\" data-tweet=\"$INVN - InvenSense hires advisor to evaluate interest; +5.88% pre-market https://seekingalpha.com/news/3218625-invensense-hires-advisor-to-evaluate-interestplus-5_88-pre-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3218625-invensense-hires-advisor-to-evaluate-interestplus-5_88-pre-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218621\" data-ts=\"1477919640\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218621-macys-on-move-after-deutsche-bank-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macy&#39;s on the move after Deutsche Bank upgrade</a></h4><ul> <li>Deutsche Bank <a href=\"http://www.cnbc.com/2016/10/31/early-movers-bhi-cah-do-sne-mgm-hlt-xom-m-de-wba-more.html\" target=\"_blank\">upgrades</a> Macy's (NYSE:<a href=\"https://seekingalpha.com/symbol/M\" title=\"Macy's Inc.\">M</a>) to a Buy rating after having the department store operator set at Neutral.</li> <li>The investment firm thinks margins could be higher at Macy's before the end of 2017 after management initiatives take hold.</li> <li>Earlier today, DB <a href=\"https://seekingalpha.com/news/3218587-deutsche-bank-takes-breather-nordstrom\" target=\"_blank\">cooled off</a> on Nordstrom after that stock's strong run.</li> <li>M <font color=\"green\">+1.80%</font> premarket to $36.20 vs. a 52-week trading range of $29.94 to $52.48.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218621\" data-linked=\"Macy&#39;s on the move after Deutsche Bank upgrade\" data-tweet=\"$M - Macy&#39;s on the move after Deutsche Bank upgrade https://seekingalpha.com/news/3218621-macys-on-move-after-deutsche-bank-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3218621-macys-on-move-after-deutsche-bank-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218611\" data-ts=\"1477918815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHKP\" target=\"_blank\">CHKP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218611-check-point-software-technologiesplus-3_7-q3-above-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Check Point Software Technologies +3.7%, Q3 above estimates</a></h4><ul>\n<li>\n<strong><a href=\"https://seekingalpha.com/news/3218510-check-point-software-technologies-beats-0_05-beats-revenue\" target=\"_blank\">Results</a></strong> \u2013 revenue $427.57M (+5.9% Y/Y, <font color=\"green\">$4.78M above estimates</font>), EPS $1.13 (<font color=\"green\">$0.05 above estimates</font>), operating income $231M (vs. $228M Y/Y), net income $194M (vs. $188M Y/Y), deferred revenue $889M (+15% Y/Y)</li>\n<li>\n<strong>Segment revenues</strong> \u2013 Products and licenses $136.9M (vs. $135.2M Y/Y), Software Blades subscriptions $98.5M (vs. $79.6M Y/Y), Software updates and maintenance $192.068M (vs. $189.016M Y/Y)</li>\n<li>\n<strong>Q4 projections</strong> \u2013 revenue $460M-$490M, EPS $1.20-$1.28</li>\n<li>Check Point Software Technologies (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CHKP\" title=\"Check Point Software Technologies Ltd.\">CHKP</a>) founder and CEO Gil Shwed: \"Customers continue to leverage the Check Point security platform and increase their adoption of our advanced security capabilities which is resulting in higher subscription revenues. We continued to see strong sales of our SandBlast, Zero Day Protection solutions, resulting in triple-digit growth as customers focus on prevention.\"</li>\n<li><a href=\"https://seekingalpha.com/symbol/CHKP/earnings\" target=\"_blank\">Prior quarters overview</a></li>\n<li><a href=\"http://edge.media-server.com/m/p/x3iea576\" target=\"_blank\">Conference call</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218611\" data-linked=\"Check Point Software Technologies +3.7%, Q3 above estimates\" data-tweet=\"$CHKP - Check Point Software Technologies +3.7%, Q3 above estimates https://seekingalpha.com/news/3218611-check-point-software-technologiesplus-3_7-q3-above-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3218611-check-point-software-technologiesplus-3_7-q3-above-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218613\" data-ts=\"1477918726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218613-fda-signs-off-on-design-of-catalyst-pharmas-late-stage-study-of-firdapse-in-lems-shares-up-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA signs off on design of Catalyst Pharma&#39;s late-stage study of Firdapse in LEMS; shares up 14% premarket</a></h4><ul>\n<li>Nano cap Catalyst Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a>) is up <font color=\"green\">14%</font> premarket on average volume on response to its announcement that the FDA has approved the company's protocol for its second Phase 3 clinical trial assessing Firdapse (amifampridine phosphate) for the treatment of symptoms of <a href=\"https://en.wikipedia.org/wiki/Lambert%E2%80%93Eaton_myasthenic_syndrome\" target=\"_blank\">Lambert-Eaton myasthenic syndrome</a> (LEMS), a rare autoimmune disorder characterized by muscle weakness in the limbs.</li>\n<li>The two-site, double-blind, placebo-controlled, parallel design withdrawal study will enroll ~28 patients. The co-primary endpoints will be the same as the first Phase 3: the change from baseline in Quantitative Myasthenia Gravis at Day 14 and the change from baseline in Subject Global Impression (SGI) score at Days 8 and 14. The trial should commence this quarter.</li>\n<li>Earlier this year, the company received a \"Refusal to File\" letter from the FDA in response to its initial NDA submission, meaning that the filing was incomplete and would require additional data.</li>\n<li>\n<a href=\"http://catalystpharma.com/pdf/CPP14005_ANAPoster_RD19M.pdf\" target=\"_blank\">Amifampridine</a> enhances neuromuscular transmission by blocking the potassium channel. This causes depolarization of the presynaptic membranes which opens the calcium channel thereby enabling muscle fibers to contract.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218613\" data-linked=\"FDA signs off on design of Catalyst Pharma&#39;s late-stage study of Firdapse in LEMS; shares up 14% premarket\" data-tweet=\"$CPRX - FDA signs off on design of Catalyst Pharma&#39;s late-stage study of Firdapse in LEMS; shares up 14% premarket https://seekingalpha.com/news/3218613-fda-signs-off-on-design-of-catalyst-pharmas-late-stage-study-of-firdapse-in-lems-shares-up-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3218613-fda-signs-off-on-design-of-catalyst-pharmas-late-stage-study-of-firdapse-in-lems-shares-up-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218602\" data-ts=\"1477917491\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SXCP\" target=\"_blank\">SXCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218602-suncoke-energy-proposes-to-buy-all-remaining-suncoke-partners-units\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunCoke Energy proposes to buy all remaining SunCoke Partners units</a></h4><ul>     <li>SunCoke Energy Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/SXCP\" title=\"SunCoke Energy Partners\">SXCP</a>) <font color=\"green\">+3.8%</font> premarket after saying it received a proposal from SunCoke Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/SXC\" title=\"SunCoke Energy\">SXC</a>) to acquire all its common units at an implied purchase price of $17.80/share, a 5% premium from Friday's closing price.</li>     <li>Under the terms of the proposal that would make SXCP a wholly-owned subsidiary of SXC, SXCP common unitholders would receive ~1.65 new shares of SXC common stock for each SXCP common unit on the NYSE.</li>     <li>Through its affiliates, SXC already owns 53.9% of SXCP\u2019s outstanding common units.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218602\" data-linked=\"SunCoke Energy proposes to buy all remaining SunCoke Partners units\" data-tweet=\"$SXCP $SXCP $SXC - SunCoke Energy proposes to buy all remaining SunCoke Partners units https://seekingalpha.com/news/3218602-suncoke-energy-proposes-to-buy-all-remaining-suncoke-partners-units?source=tweet\" data-url=\"https://seekingalpha.com/news/3218602-suncoke-energy-proposes-to-buy-all-remaining-suncoke-partners-units\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218593\" data-ts=\"1477916707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTB\" target=\"_blank\">CTB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218593-on-cooper-tire-rubbers-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Cooper Tire &amp; Rubber&#39;s Q3</a></h4><ul>     <li>Cooper Tire &amp; Rubber (NYSE:<a href=\"https://seekingalpha.com/symbol/CTB\" title=\"Cooper Tire &amp; Rubber Co.\">CTB</a>) reports unit volume was flay Y/Y in Q3.</li>     <li>Americas tire sales dropped 4.2% to $673M.</li>     <li>International tire sales fell 5.1% to $113M, volume declined 4.7%.</li>     <li>Gross margin rate expanded 70 bps to 20.4%.</li>     <li>SG&amp;A expense rate improved 80 bps to 8.4% primarily due to decreased incentive compensation and lower brand and marketing program expense.</li>     <li>Operating margin rate down 10 bps to 10.4%.</li>     <li>Americas tire operating margin rate grew 50 bps to 15.1%.</li>     <li>\n<b>FY2016 Guidance</b>: Effective tax rate: 32% to 34%; Operating margin rate: modestly up Y/Y; Capex: $180M to $200M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3218593\" data-linked=\"More on Cooper Tire &amp; Rubber&#39;s Q3\" data-tweet=\"$CTB - More on Cooper Tire &amp; Rubber&#39;s Q3 https://seekingalpha.com/news/3218593-on-cooper-tire-rubbers-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3218593-on-cooper-tire-rubbers-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218592\" data-ts=\"1477916572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZBH\" target=\"_blank\">ZBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218592-zimmer-biomet-q3-top-line-up-4-non-gaap-eps-up-9-downward-revision-of-revenue-growth-sinks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zimmer Biomet Q3 top line up 4%; non-GAAP EPS up 9%; downward revision of revenue growth sinks shares, down 6% premarket</a></h4><ul>\n<li>Zimmer Biomet Holdings (NYSE:<a href=\"https://seekingalpha.com/symbol/ZBH\" title=\"Zimmer Biomet Holdings, Inc.\">ZBH</a>) Q3 results ($M): Total Revenues: 1,832.8 (+4.0%); Americas: 1,175.9 (+3.7%); EMEA: 368.8 (-1.7%); Asia Pacific: 288.1 (+13.6%).</li>\n<li>Knees: 631.3 (-0.1%); Hips: 440.6 (+1.6%); S.E.T.: 402.1 (+8.6%); Dental: 95.9 (-7.3%); Spine &amp; CMF: 183.6 (+24.3%).</li>\n<li>Net Income: 158.8 (+615.3%); Non-GAAP Net Income: 362.4 (+7.1%); EPS: 0.78 (+609.1%); Non-GAAP EPS: 1.79 (+9.1%); CF Ops (9 mo.): 1,005.0 (+159.5%).</li>\n<li>\n<strong>2016 Guidance</strong>: Revenues: $7.63B - 7.65B; Revenue growth excluding LDR Holding (constant currency adjusted pro forma basis): 1.65 - 1.90% from 2.5 - 3.0%; EPS: $1.60 - 1.50; Non-GAAP EPS: $7.95 - 7.90.</li>\n<li>Consensus view was EPS of $1.79 on revenues of $1.8B.</li>\n<li>Shares are down <font color=\"red\">6%</font> premarket on light volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218592\" data-linked=\"Zimmer Biomet Q3 top line up 4%; non-GAAP EPS up 9%; downward revision of revenue growth sinks shares, down 6% premarket\" data-tweet=\"$ZBH - Zimmer Biomet Q3 top line up 4%; non-GAAP EPS up 9%; downward revision of revenue growth sinks shares, down 6% premarket https://seekingalpha.com/news/3218592-zimmer-biomet-q3-top-line-up-4-non-gaap-eps-up-9-downward-revision-of-revenue-growth-sinks?source=tweet\" data-url=\"https://seekingalpha.com/news/3218592-zimmer-biomet-q3-top-line-up-4-non-gaap-eps-up-9-downward-revision-of-revenue-growth-sinks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218589\" data-ts=\"1477915875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMH\" target=\"_blank\">TMH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218589-teamhealth-sold-to-blackstone-for-6_1b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TeamHealth sold to Blackstone for $6.1B</a></h4><ul>\n<li>The all-cash deal works out to $43.50 per share, a 33% premium to TeamHealth's (NYSE:<a href=\"https://seekingalpha.com/symbol/TMH\" title=\"Team Health Holdings, Inc.\">TMH</a>) close on Oct. 3, the day before reports the company was mulling a sale. TMH closed at $36.80 on Friday.</li>\n<li>Jana Partners approves the deal and will vote its roughly 8% stake in favor of it.</li>\n<li>There's a 40-day go-shop period. Closing is expected in Q1.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218589\" data-linked=\"TeamHealth sold to Blackstone for $6.1B\" data-tweet=\"$TMH $BX - TeamHealth sold to Blackstone for $6.1B https://seekingalpha.com/news/3218589-teamhealth-sold-to-blackstone-for-6_1b?source=tweet\" data-url=\"https://seekingalpha.com/news/3218589-teamhealth-sold-to-blackstone-for-6_1b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218583\" data-ts=\"1477915272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARIA\" target=\"_blank\">ARIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218583-fda-to-review-ariads-brigatinib-nda-for-lung-cancer-action-date-april-29-2017\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA to review ARIAD&#39;s brigatinib NDA for lung cancer; action date April 29, 2017</a></h4><ul>\n<li>The FDA accepts for review ARIAD Pharmaceuticals' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a>) New Drug Application (NDA) seeking approval of brigatinib for the treatment of patients with ALK-positive non-small cell lung cancer (NSCLC) who have progressed on crizotinib [Pfizer's (NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>) <a href=\"http://www.xalkori.com/\" target=\"_blank\">XALKORI</a>]. The agency's action date (PDUFA) is April 29, 2017 under Priority Review status.</li>\n<li>The company expects to file its marketing application in Europe in Q1.</li>\n<li>\n<a href=\"http://www.ariad.com/research-development/brigatinib/\" target=\"_blank\">Brigatinib </a>is an oral inhibitor of an enzyme called <a href=\"https://en.wikipedia.org/wiki/Anaplastic_lymphoma_kinase\" target=\"_blank\">anaplastic lymphoma kinase</a> (ALK). The abnormal expression of ALK is a key driver of certain types of non-small cell lung cancer, neuroblastomas and anaplastic large cell lymphoma. It is not generally expressed in normal adult tissues so it is a promising therapeutic target.</li>\n<li>Shares are up <font color=\"green\">2%</font> premarket on light volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218583\" data-linked=\"FDA to review ARIAD&#39;s brigatinib NDA for lung cancer; action date April 29, 2017\" data-tweet=\"$ARIA $ARIA $PFE - FDA to review ARIAD&#39;s brigatinib NDA for lung cancer; action date April 29, 2017 https://seekingalpha.com/news/3218583-fda-to-review-ariads-brigatinib-nda-for-lung-cancer-action-date-april-29-2017?source=tweet\" data-url=\"https://seekingalpha.com/news/3218583-fda-to-review-ariads-brigatinib-nda-for-lung-cancer-action-date-april-29-2017\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218559\" data-ts=\"1477913311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218559-nike-on-watch-after-baml-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike on watch after BAML downgrade</a></h4><ul> <li>Bank of America Merrill Lynch <a href=\"http://www.streetinsider.com/Downgrades/BofAMerrill+Lynch+Downgrades+Nike+%28NKE%29+to+Underperform/12183623.html\" target=\"_blank\">downgrades</a> Nike (NYSE:<a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a>) to an Underperform rating after having it previously set at Neutral.</li> <li>The investment firm predicts an erosion of market share to Under Armour and Adidas in Asia and other key markets.</li> <li>An update on futures orders will be the highlight of Nike's next earnings report due out in December.</li>\n<li>Shares of Nike are <font color=\"red\">down 1.85%</font> premarket to $51.06 vs. a 52-week trading range of $50.71 to $68.19.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3218559\" data-linked=\"Nike on watch after BAML downgrade\" data-tweet=\"$NKE - Nike on watch after BAML downgrade https://seekingalpha.com/news/3218559-nike-on-watch-after-baml-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3218559-nike-on-watch-after-baml-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218527\" data-ts=\"1477910630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTL\" target=\"_blank\">CTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218527-centurylink-to-acquire-level-3-for-34b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CenturyLink to acquire Level 3 for ~$34B</a></h4><ul>     <li>CenturyLink (NYSE:<a href=\"https://seekingalpha.com/symbol/CTL\" title=\"CenturyLink, Inc.\">CTL</a>) and Level 3 Communications, Inc. (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LVLT\" title=\"Level 3 Communications, Inc.\">LVLT</a>) announce that CenturyLink will acquire Level 3 in a cash and stock transaction valued at approximately $34B, including the assumption of debt.</li>         <li>LVLT shareholders will receive $26.50/share and 1.4286 shares of CTL stock for each Level 3 share they own, which implies a purchase price of $66.50/LVLT share - a premium of approximately 42% based on Level 3's unaffected closing share price of $46.92 on 26-Oct-16, the last trading day prior to <a href=\"https://seekingalpha.com/news/3217669-centurylink-plus-5_2-percent-level-3-plus-7_2-percent-report-merger-talks\" target=\"_blank\">market speculation</a> about a potential transaction.</li>         <li>Upon the closing of the transaction, CenturyLink shareholders will own approximately 51% and Level 3 shareholders will own approximately 49% of the combined company.</li>         <li>The combined company will have approximately $19B in pro forma business revenue and $13B in business strategic revenue.</li>                 <li>Combined company is expected to have improved adjusted Ebitda margins, revenue growth and pro forma net leverage of less than 3.7x at close, including run-rate synergies. The combined company will benefit from Level 3's nearly $10B of net operating losses. These NOLs will substantially reduce the combined company's net cash tax expense over the next several years, positioning it to generate substantial free cash flow.</li>                 <li>CenturyLink expects to maintain its annual dividend of $2.16 per share.</li>                 <li>Conference call today at 8:00 AM ET. (866) 610-1072 within the U.S. and (973) 935-2840 for all other locations. Confirmation code is 10841687.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3218527\" data-linked=\"CenturyLink to acquire Level 3 for ~$34B\" data-tweet=\"$CTL $CTL $LVLT - CenturyLink to acquire Level 3 for ~$34B https://seekingalpha.com/news/3218527-centurylink-to-acquire-level-3-for-34b?source=tweet\" data-url=\"https://seekingalpha.com/news/3218527-centurylink-to-acquire-level-3-for-34b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3218526\" data-ts=\"1477910517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LVLT\" target=\"_blank\">LVLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3218526-level-3-misses-0_03-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Level 3 misses by $0.03, misses on revenue</a></h4><ul><li>Level 3 (NASDAQ:<a href='https://seekingalpha.com/symbol/LVLT' title='Level 3 Communications, Inc.'>LVLT</a>): Q3 EPS of $0.39 <font color='red'>misses by $0.03</font>.</li><li>Revenue of $2.03B (-1.5% Y/Y) <font color='red'>misses by $40M</font>.</li><li>Shares <font color='green'>+3.89%</font> PM.</li></ul><div class=\"tiny-share-widget\" data-id=\"3218526\" data-linked=\"Level 3 misses by $0.03, misses on revenue\" data-tweet=\"$LVLT - Level 3 misses by $0.03, misses on revenue https://seekingalpha.com/news/3218526-level-3-misses-0_03-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3218526-level-3-misses-0_03-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:41 AM </div></div></li>","count":69,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}